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Overview 
Part 1 is a literature review exploring the functional neuroanatomy of pain and 
psychological modulation of the pain experience. The focus of the review is a 
description and evaluation of peer reviewed research on functional brain imaging of 
hypnosis induced pain relief. The findings are summarised and discussed in the context 
of generalizability. Future research and clinical implications are then outlined. 
Part 2 is a research study exploring the processes, application, clinical benefits and 
potential mechanisms of hypnosis for chronic pelvic pain. A mixture of quantitative and 
qualitative methods were employed to assess a number of psychological and sensory (i.e. 
pain) changes from baseline to end of treatment. All participants completed the study. 
Overall, the results suggest that participants benefited from hypnosis treatment but that 
such benefits varied between individuals in terms of sensory, psychological and 
behavioural effects such as pain relief, acceptance of pain and engaging in more activity. 
Several of these benefits were clinically significant and reliable, notably in terms of pain 
reduction and less catastrophizing. 
Part 3 is a critical appraisal. Here reflections on the research process, from conducting 
the study for the empirical paper are discussed. 	  
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1 Part 1: Literature Review 
Functional Neuroanatomy of Hypnotic Analgesia in 
Chronic Pain:  What Have we Learned From Functional 
Neuroimaging? 
 Abstract 1.1
Background: Hypnosis is commonly used as an intervention for treating chronic pain, 
the mechanisms of which are likely to be neuropsychological. Whilst mechanisms of 
modulating chronic pain in health has been well described, there is a paucity of available 
synthesised information on mechanisms in individuals suffering with chronic pain. 
Aims: The aim of this review is to assess and critically evaluate current knowledge on 
the role of the brain in hypnotic analgesia of patients suffering with chronic pain. 
Methods: A systematic search of PsychINFO, Medilne and Embase was carried out. 
This search identified nine papers suitable for addressing the research aims. Results: 
The studies reviewed highlighted considerable variability in methodology and outcomes 
of research on brain mechanisms of hypnosis induced analgesia in chronic pain. 
Nonetheless, the most common brain regions implicated in the studies reviewed 
(anterior cingulate cortex, insula, thalamus, secondary somatosensory cortex and frontal 
cortex) overlap with those show to be involved in processing of pain in health and 
chronic pain. Moreover, these regions are predominately those previously implicated in 
more emotional and cognitive modulation of pain. In addition, baseline brain state 
appears to be linked to effectiveness of hypnotic analgesia. Conclusions: Given the 
relatively small number of studies available for review, there are limitations on the 
conclusions that can be drawn. As such, recommendations are made for future research 
including the need for larger sample sizes and more complex brain image acquisition 
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and analysis. Baseline brain state may predict response to hypnotic analgesia. There may 
be a role for assessing this before commencing hypnosis treatment.  
 
 Introduction 1.2
Overview of review 
The aim of this review is to assess and critically evaluate current knowledge on 
the role of the brain in hypnotic analgesia of patients suffering with chronic pain. An 
overview of pain, functional brain imaging and the neuroanatomy of pain will be 
presented, followed by a description of clinical hypnosis and summary of research on 
brain processing of hypnosis. There follows a description of systematic search methods 
used to identity current literature on functional brain imaging of hypnotic analgesia in 
chronic pain patients. Finally a summary and critical evaluation of the current literature 
will be presented with implications for future research and clinical practice.  
 
 The Pain ‘Matrix’ 1.3
What is pain? 
The International Association for the Study of Pain defines pain as “an 
unpleasant sensory and emotional experience associated with actual or potential tissue 
damage” (Merskey & Bogduk, 1994). Importantly, this definition avoids linking pain to 
the stimulus that produced it and highlights the emotional (“unpleasant”) and cognitive 
aspects (“potential” tissue damage). This definition reflects the fact that pain can 
originate centrally and is therefore often experienced in the absence of observable 
organic sensory pathology (often referred to as functional pain syndrome or 
unexplained chronic pain) and is commonly associated with psychological factors such 
as mood and attention.  
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Chronic pain 
Chronic pain occurs when symptoms persist beyond the normal acute period of 
tissue damage and healing time (greater that 3-6 months). It is debilitating physically and 
psychologically, affects approximately 20%-40% of the population and is a global 
phenomenon (Breivik, Collett, Ventafridda, Cohen, & Gallacher, 2006). It is generally 
well accepted that in chronic pain disorders psychological factors such as emotional and 
cognitive processing, as well as stress, play an important role in symptomatology. This is 
reflected in the high association of anxiety and depression in individuals suffering with 
chronic pain (estimated at between 20-40% (McWilliams, Cox, & Enns, 2003)). 
Dimensions of Pain 
Broadly speaking, contemporary theories consider pain a multidimensional 
experience consisting of sensory (localisation and intensity of pain), cognitive (aspects such 
as attention to pain), affective (level of negative affect associated with pain) and 
behavioural components rather than the somewhat dated dualistic approach which 
viewed pain as “organic” or “psychological” (R. Melzack, 1999, 2001, 2005; Ronald 
Melzack & Casey, 1968; Treede, Kenshalo, Gracely, & Jones, 1999).  These theories 
emphasize the fact that the experience of pain is not simply related to the level of 
nociceptive input but is modulated by “top-down” factors such as mood, pain 
memories and hypervigilance, for example. 
 
Sensory-Discriminative Dimension of Pain 
The sensory-discriminative component of pain refers to the localisation of a 
painful event to a specific region of the body as well as identifying the intensity of the 
noxious stimulus (Bushnell et al., 1999; Treede et al., 1999). Several studies have shown 
that the sensory-discriminative aspect of pain can be modulated by affective and 
cognitive components of the pain experience, resulting in changes in pain tolerance, 
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pain intensity ratings and ability to localize the region of painful stimulation (see section 
on psychological modulation of pain).  
 
Affective-Motivational Dimension of Pain 
The affective-motivational dimension of pain is more complex and comprises 
several aspects that contribute to the emotional experience of pain including 
unpleasantness, fear and anxiety during and immediately following a painful event.  
In addition, this dimension also refers to emotional feelings regarding the long-term 
implications of living with ongoing, persistent pain such as hopelessness, depression and 
anger (Price, 2000)(Donald D. Price & Harkins, 1992). 
 
Cognitive-Evaluative dimension of Pain 
The cognitive-evaluative component of the pain encompasses aspects such as 
attention, learning and anticipation (Bantick et al., 2002; Coen et al., 2008; Gregory et 
al., 2003; Ploghaus et al., 1999; I. Tracey et al., 2002; Treede et al., 1999; Yaguez et al., 
2005) as well as past experience of pain, beliefs about pain and constructs such as 
acceptance (R. Melzack, 1999; Ronald Melzack & Casey, 1968; R. Melzack & Chapman, 
1973). 
 
 Psychological modulation of pain 1.4
The three components of pain processing interact such that one can affect 
another. For example, using experimentally induced pain, experimenters have 
demonstrated that negative emotional states can increase pain perception and reduce 
pain tolerance (Hertel & Hekmat, 1994; Meagher, Arnau, & Rhudy, 2001; Phillips et al., 
2003; N. K. Y. Tang et al., 2008; Weisenberg, Raz, & Hener, 1998; Whipple & Glynn, 
1992; Zelman, Howland, Nichols, & Cleeland, 1991). whilst a positive emotional state 
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has been shown to increase pain tolerance and decrease pain perception (Roy, Peretz, & 
Rainville, 2003; Villemure, Slotnick, & Bushnell, 2003; Whipple & Glynn, 1992; Zelman 
et al., 1991; Zillmann, de, King-Jablonski, & Jenzowsky, 1996). Furthermore, 
experimenters have reported increased pain thresholds and lowered pain scores when 
volunteers are distracted from a painful stimulus (Bushnell et al., 1999; Levine, Gordon, 
Smith, & Fields, 1982; Miron, Duncan, & Bushnell, 1989; Rode, Salkovskis, & Jack, 
2001). And that when individuals focus their attention towards pain they report higher 
pain scores, suggesting that focussing attention on pain enhances pain perception 
(Levine et al., 1982; Miron et al., 1989).  
Furthermore, individual differences in personality traits such as neuroticism and 
trait anxiety have also been shown to be related to inter-individual differences in pain 
tolerance and pain perception (Farmer et al., 2013; Ruffle et al., 2015; J. Tang & Gibson, 
2005).  
The mechanisms of the psychological modulation of nociception are not fully 
understood but it is clear from numerous studies that the brain is where pain perception 
and thus modulation takes place (Bingel & Tracey, 2008). 
 
 Functional neuroanatomy of pain processing 1.5
Much of what we know about the functional role of brain regions involved in the 
processing of nociception come from functional neuroimaging studies, which have 
increased exponentially since the introduction of brain imaging methods such as 
functional magnetic resonance imaging (fMRI) and positron emission tomography 
(PET) approximately 20 years ago. These studies have reported brain activation in 
response to a variety of pain stimuli (e.g. mechanical, chemical, heat, electrical) in health 
and chronic pain using a range of brain imaging methods (e.g. fMRI, PET, cortical 
evoked potentials [CEPs) and electroencephalography [EEG]). 
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The main underlying principles of the most commonly used functional 
neuroimaging imaging approaches are summarised in Figure 1.1. Electrophysiological 
approaches (MEG and EEG) detect direct electrical activity, thereby providing excellent 
temporal resolution of function (milliseconds). However, these approaches are limited 
in their spatial resolution and largely confined to measuring cortical activity with limited 
validity in accuracy of localization when measuring subcortical activity i.e. MEG. As a 
result of these limitations, electrophysiological approaches are mostly employed to 
assess temporal aspects of cortical function to acute stimuli. In addition to stimulus 
evoked activity, EEG has also been used extensively to measure spontaneous 
fluctuations in electrical activity (e.g. alpha, theta, gamma waves) at rest and during 
experimental challenges such as pain or hypnotic induction.  
 
 
Figure 1.1 Summary of main principles of various neuroimaging techniques 
 
 
In contrast, PET and fMRI measure blood flow, blood oxygenation or local 
metabolic changes that are indirect measures of neuronal activity. These methods are 
the most extensively used approaches in functional neuroimaging research. PET and 
fMRI have lower temporal resolution than the electrophysiological approaches (PET 
>60 seconds; fMRI 2-3 seconds) but have the advantage of excellent spatial resolution 
and ability to measure activity in subcortical structures. Whilst fMRI is a non-invasive 
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approach, PET requires injection of a radioligand and although this limits serial scans it 
does provide a window for examining specific neurotransmitters or receptors, giving it a 
biological specificity, unlike fMRI (Mayer et al., 2009).  
Despite the heterogeneity in study methods a consensus has been reached 
regarding a network of brain regions involved in pain processing, commonly referred to 
as the pain neuromatrix. This cerebral signature of pain is most commonly defined as 
the primary somatosensory cortex (S1), secondary somatosensory cortex (S2), anterior 
cingulate cortex (ACC), prefrontal cortex (PFC), insula, and the thalamus, see Figure 1.2  
(Apkarian, Bushnell, Treede, & Zubieta, 2005; I. Tracey, 2008). Given the multi-factorial 
influences on pain perception, the pain neuromatrix can be considered somewhat 
simplistic and researchers have acknowledged that this neuromatrix overlaps with other 
cognitive, emotional and sensory (non-nociceptive) stimuli and may represent a 
common brain response to salient sensory and emotional stimuli (Legrain, Iannetti, 
Plaghki, & Mouraux, 2011; Mouraux, Diukova, Lee, Wise, & Iannetti, 2011; I. Tracey, 
2008). Nevertheless, the cerebral signature of pain, as it is now commonly described 
(Irene Tracey & Mantyh, 2007), is a summary of current knowledge on brain 
involvement and has been defined as comprising lateral (sensory-discriminatory, 
including regions such as the S1, S2, posterior insula and thalamus) and medial 
(affective-cognitive-evaluative components, including regions such as the PFC, anterior 
insula and ACC) functional neuroanatomical divisions (I. Tracey, 2008). Other regions 
that are also commonly reported in functional neuroimaging studies on pain include the 
amygdala, cerebellum and hippocampus. The exact nature of activity in any given study 
depends on a multitude of factors including the population being studied (chronic pain 
patients/healthy volunteers), stimulus type, imaging modality and experimental design. 
Although the influence of inter-individual variability is diminished by studying and 
summarising groups in functional imaging studies, there are likely to be differences in 
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genetics, neurotransmitters, autonomic function and psychological responses to pain 
that also contribute to the composite of brain activity reported in any given study 
(Farmer et al., 2013).  For a schematic summary of the main factors known to modulate 
pain perception see Figure 1.3. 
 
Figure 1.2 Cerebral signature of pain. fMRI data rendered onto structural MRI image, depicting 
brain activity (from bottom to top of brain) during pain in the brainstem (thalamus), insula 
primary and secondary somatosensory cortices and the anterior cingulate cortex. Figure adapted 
from Bingel & Tracey (2008). 
 
 
Overview of main brain regions involved in pain processing  	
Primary Somatosensory Cortex:  
Previous functional imaging studies have shown evidence that the primary 
somatosensory cortex has an important role to play in processing visceral and somatic 
sensations (Aziz et al., 2000; Bushnell et al., 1999; Coghill, Sang, Maisog, & Iadarola, 
1999; Craig, Reiman, Evans, & Bushnell, 1996; S. W. Derbyshire et al., 1997; Kenshalo 
& Willis, 1991; Porro, Cettolo, Francescato, & Baraldi, 1998). Many of these studies 
have highlighted the role of the SI in processing sensory-discriminative aspects of non-
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painful and painful somatic and visceral sensations, such as spatial discrimination and 
intensity. Indeed, several studies have shown brain activity in this region increases with 
rising sensory input suggesting the intensity of a stimulus is encoded in the SI (Bushnell 
et al., 1999)(Coen et al., 2008; Coen et al., 2007). 
Several studies have also suggested the SI may be also important in processing 
affective (Hofbauer, Rainville, Duncan, & Bushnell, 1998; D. D. Price, 2000; D. D. 
Price & Verne, 2002) and cognitive dimensions of pain (Bushnell et al., 1999; Coghill et 
al., 1999; Porro et al., 1998). 
 
Secondary Somatosensory Cortex:  
The secondary somatosensory cortex receives afferents from the primary 
somatosensory cortex, and also from the thalamus (Stevens, London, & Apkarian, 
1993). There is evidence to suggest that S2 plays a role in serial secondary processing of 
incoming sensory information after processing has taken place in the S1 (Mauguiere et 
al., 1997). However. it has also been suggested that the S2 may be involved in attention 
to painful events rather than being involved in the sensory discriminative aspects of 
sensations (Kenshalo & Willis, 1991). However, lesion studies in primates have 
provided evidence to suggest that S2 contributes to texture and shape discrimination 
(somethetic function) (Garcha & Ettlinger, 1978, 1980; Murray & Mishkin, 1984). 
 
Anter ior  Cingulate  Cortex:  
The anterior cingulate cortex (ACC) has been activated in many studies of pain 
processing and sensory stimulation. It is generally broken down into two regions; the 
perigenual region of the ACC (BA32) and the mid-ACC (BA24). 
The perigenual region of the cingulate (BA32) has direct connections with 
brainstem autonomic nuclei and is believed to play a role in the management of 
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autonomic and emotional reactions to external stimuli, (Devinsky, Morrell, & Vogt, 
1995; Vogt, Derbyshire, & Jones, 1996). The mid-ACC (BA24) has connections with 
the motor cortex and has been shown to be mainly involved in response decisions, 
attention and preparatory motor functions (Devinsky et al., 1995; Vogt et al., 1996) as 
well as being involved in the anticipation of pain (Yaguez et al., 2005). The mid-anterior 
cingulate gyrus has also been shown to be activated by negative emotions (Bush, Luu, & 
Posner, 2000; George et al., 1995; Phillips et al., 2003; Rainville, Carrier, Hofbauer, 
Bushnell, & Duncan, 1999; Rainville, Duncan, Price, Carrier, & Bushnell, 1997; Tolle et 
al., 1999) and processing the unpleasantness of pain which has been shown to positively 
correlate with activity in this region (Rainville et al., 1999; Rainville et al., 1997; Tolle et 
al., 1999). 
Several studies have also shown association of activity in this region with level of 
sensory input such that activity increases with increasing pain, suggesting a function of 
encoding of stimulation intensity and therefore in sensory-discriminative aspects of pain 
processing (Bernstein et al., 2002; Binkofski, 2000; Brooks, Nurmikko, Bimson, & 
Roberts, 2002; Porro et al., 1998). More recent findings suggest a multi-functional role 
of the mid ACC in processing sensory and cognitive aspects of painful stimulation 
(Coen et al., 2008). 
 
Insula:  
The insula is perhaps the most common area of brain activation following 
painful stimulation (Apkarian et al., 2005; Peyron, Laurent, & Garcia-Larrea, 2000) and 
is generally divided into the anterior and posterior regions. 
There is little evidence to suggest the insula is specific to pain as activation in 
this region has been shown in response to a variety of non-noxious stimuli including 
electrical, tactile, vibratory and thermal sensations (Coghill, Sang, Berman, Bennett, & 
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Iadarola, 1998; Coghill et al., 1994; Craig et al., 1996; Iadarola et al., 1998; Mauguiere et 
al., 1999). However, functional imaging studies have shown that mid-posterior insula 
activity increases with intensity of thermal stimulation (Coghill et al., 1999; Peyron et al., 
1999).  
In contrast, the anterior insula is believed to be involved in the affective responses to 
pain (Coen et al., 2009; Phillips et al., 2003) and interoception (Craig, 2002, 2003). Injury 
in the form of lesions to the anterior insula results in diminished affective responses, but 
does not affect the spatial discriminative aspects of a painful experience. 
 
Thalamus:   
The thalamus is made up of several nuclei and is where nociception information 
enters the brain from the periphery; from this region sensory information is transmitted 
to limbic and cortical brain regions. As well as being implicated in pain processing, 
activation of the thalamus has been shown to increase during periods of vigilance or 
attention suggesting the thalamus has a more specific role in mediating general arousal 
reactions to pain (Lowey AD, 1990).  
 
Pre- frontal  cor tex:  
Previous studies involving pain have identified the right ventrolateral prefrontal 
cortex as being involved in corticolimbic inhibition of pain (Berman et al., 2008; Lorenz, 
Minoshima, & Casey, 2003; Mayer, Naliboff, & Craig, 2006). There is a well-
characterized opiate-sensitive descending pathway which descends from the frontal 
cortex to the amygdala, PAG, rostral ventral medulla to the spinal dorsal horn (Fields, 
2000; Villemure & Bushnell, 2002) that is thought to be involved in pain inhibition. 
Other researchers have also found increased activity in the dorsolateral PFC associated 
with a decrease in pain ratings during cognitive processes such as placebo analgesia and 
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distraction from pain (Coen et al., 2008; Kong et al., 2006; Kong, Kaptchuk, Polich, 
Kirsch, & Gollub, 2007).  
 
 Brain function in chronic pain 1.6
Studies have shown that brain activity in patients with chronic pain overlaps with 
that seen in normal subjects to experimental pain but that there is a tendency for lower 
activity in clinical populations in most regions. However, it has also been suggested that 
PFC activity is more prevalent in functional imaging studies involving patients with 
chronic pain and that the activity reflects the added burden of cognitive and affective 
impact of chronic pain (Apkarian et al., 2005). It should be noted however that 
differences between clinical and healthy populations may be accounted for by various 
factors, not least the effect of co-morbid symptoms commonly found in clinical pain 
populations (Elsenbruch et al., 2010). Moreover, the causality i.e. whether brain activity 
was different in chronic pain patients as a result of chronic pain or prior to pain 
symptoms is not clear and requires longitudinal imaging studies are required that also 
assess other biological, psychological and environmental factors that contribute to 
chronic pain.  
 
 Functional neuroanatomy of psychological modulation of pain 1.7
As previously described, experimental evidence suggests that pain tolerance 
increases during distraction and positive emotional modulation. but decreases when 
attention is focused on pain or during negative emotional modulation (Coen et al., 2008; 
Phillips et al., 2003; N. K. Y. Tang et al., 2008; I. Tracey et al., 2002; Villemure et al., 
2003; Zelman et al., 1991). Using brain imaging techniques, researchers have shown a 
neurological basis of psychological modulation of pain which typically involves regions 
such as the anterior insula and anterior cingulate cortex ([ACC] emotional modulation) 
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(Berna et al., 2010; Coen et al., 2009; Phillips et al., 2003; Rainville, 2002; Rainville et al., 
1997) and frontal cortex and ACC (cognitive modulation) (Bantick et al., 2002; Coen et 
al., 2008; Dunckley et al., 2007; Kulkarni et al., 2005; Petrovic, Petersson, Ghatan, 
Stone-Elander, & Ingvar, 2000; Tolle et al., 1999; Valet et al., 2004). In addition, several 
studies have shown activity of the cerebral signature of pain during the anticipation of 
pain (in the absence of a physical stimulus), highlighting the importance of expectation 
on the pain experience (Ploghaus et al., 1999; Villemure & Bushnell, 2002; Yaguez et al., 
2005). Finally, several studies have also shown the periaqueductal grey matter and 
hippocampal network to be important in emotional and cognitive inhibition and 
facilitation of pain (Ploghaus et al., 2001; I. Tracey et al., 2002). 
More recently, there has been a shift away from correlating individual loci of pain 
activity with function and a move towards studying networks (e.g. emotional arousal, 
salience and sensorimotor networks) involved in psychological modulation through the 
use of connectivity analysis (Denk, McMahon, & Tracey, 2014; Garcia-Larrea & Peyron, 
2013; Labus et al., 2009; Labus et al., 2008; Mayer, Labus, Tillisch, Cole, & Baldi, 2015; 
Ploner, Lee, Wiech, Bingel, & Tracey, 2010; Wager et al., 2013). 
 
 Summary of neuroanatomy of pain processing 1.8
In summary, functional neuroimaging studies have helped delineate a pain 
pathway whereby afferent nociceptive information is transmitted through the thalamus 
to the S1, S2, IC, ACC and PFC. Whilst there appear to be differences between chronic 
and experimental pain (i.e. more activity seen in PFC in chronic pain, less activity in 
other areas), the brain signature is broadly consistent across populations. Furthermore, a 
wealth of studies have shown how modulation of pain perception is associated with 
changes in various loci considered part of the pain signature.  
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Figure 1.3 Schematic summary of most common factors known to modulate human perception 
of nociceptive input, overlaid onto structural MRI of candidate’s (Steven Coen) brain. 
Peripheral nerves transmit nociceptive signals through the spinal column to the brain, the 
perception of the signal is influenced by factors such as attention and mood which can amplify 
or reduce the individual experience of pain.  
 
 	  
Mood:	anxiety,	depression,	fear,	catastrophizing	
Cognition:	attention,	anticipation,	beliefs,	hypervigilence,	coping	
Context:	pain	memories,	stress,	expectations,	placebo	
Genetics	e.g.	COMT	
Chemical	and	structural:	neurotransmitter	function,	atrophy/injury,	lesions	
Injury:	stimulus	type,	duration,	peipheral/central	sensitization		
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 Clinical Hypnosis 1.9
Clinical hypnosis is a procedure that results in a temporary change in individual 
state such that peripheral awareness is reduced, attention is focused and responsiveness 
to suggestion is increased. In order to achieve a hypnotic state or trance, hypnotherapy 
typically involves the use of a series of instructions such as focusing on breathing 
rhythms or using guided imagery both of which can result in a focused and absorbed 
attentional state. It is in this state or trance that targeted suggestions for a desired 
treatment are delivered. The individual is guided by the hypnotherapist to respond to 
suggestions for changes in subjective experience (e.g. level of pain), perception, 
sensation, emotion, thought or behaviour. The suggestions are often idiosyncratic 
depending on the presentation and goals of the patient (M. P. Jensen, Day, & Miro, 
2014). Hypnosis for pain often uses imagery to change the sensation of pain (e.g. 
imagining a pain dial being turned down) as well as focusing of cognitive influences on 
pain (e.g. coping, acceptance and catastrophizing) and behavioural (such as increasing 
daily function and activity). The number of sessions varies but typically intervention is 
delivered over 6-8 sessions lasting between 30 to 60 minutes.  It is common for patients 
to rehearse scripts (self hypnosis) between sessions which is often achieved by the use 
of in session recordings that the patient uses outside the therapy sessions. 
There is a growing area of research on hypnosis for treating chronic pain in a 
variety of pain conditions including musculoskeletal pain, visceral pain (e.g. irritable 
bowel syndrome) and neuropathic pain (Flik et al., 2011; Gonsalkorale & Whorwell, 
2005; Oneal, Patterson, Soltani, Teeley, & Jensen, 2008; Prior, Colgan, & Whorwell, 
1990). These studies, which have largely focused on outcomes such as pain reduction, 
have provided good evidence for reducing pain and there are now several RCTs 
showing efficacy of hypnosis for reducing pain in a range of chronic pain disorders (M. 
P. Jensen & Patterson, 2014; Tan et al., 2014). In addition, recent evidence has also 
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highlighted other beneficial side effects such as reduction in pain unpleasantness, and 
improved sleep quality, self-efficacy and confidence, mood and socializing (Crasilneck, 
1979; H. J. Crawford, 1998; Grundy et al., 2006; M. P. Jensen, 2006; R. Melzack & 
Perry, 1975; Sachs, Feuerstein, & Vitale, 1977). 
The mechanisms of hypnosis for reducing pain are still relatively poorly 
understood, although it is widely accepted that the brain is the central channel through 
which psychological (e.g. coping, hypervigilance) and physiological (e.g. autonomic 
function, muscle tension) modulation occurs. Recent developments have been achieved 
through neuroimaging work that has shown hypnosis results in changes in brain activity 
in the pain neuromatrix, suggesting top-down modulation of pain. The brain regions 
involved appear to depend on the nature of the hypnotic suggestions, i.e. whether there 
is a sensory, emotional or attention focus. Taken together these data suggest an 
alteration in the integration of sensory, cognitive and affective aspects of the pain 
experience following hypnosis. 
 
 Functional neuroanatomy of hypnosis 1.10
Before reviewing neuroimaging studies on the hypnotic modulation of pain, it is 
important to first consider the role of the brain in hypnotic modulation alone.  
  Research exploring the possible mechanisms behind hypnosis has accelerated 
rapidly in the past two decades with the introduction of neuroimaging techniques such 
as fMRI and PET. As with pain, the functional neuroanatomy of hypnosis is complex 
and there is no “hypnosis center” in the brain. (Jensen 2015).  Instead, there are several 
regions thought to be important in the efficacy of hypnosis. The complexity is made all 
the more multifaceted as studies involving brain imaging have largely compared groups 
of individuals based on how susceptible they are to hypnotic induction (high versus 
low). Furthermore, the nature of the brain involvement in hypnotic modulation is not 
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simple as the direction of activity (increased v decreased) has shown to be dependent on 
the type of hypnotic suggestion as well as inter-individual differences in hypnotic 
susceptibility. 
Nevertheless, these studies have produced a body of evidence that suggests there 
is a consistent pattern of neural responding during hypnotic induction particularly in the 
frontal cortices, mid and anterior cingulate gyrus (Helen J. Crawford, 1994; De 
Benedittis, 2003; Faymonville, Boly, & Laureys, 2006; Mark P. Jensen et al., 2015; 
Rainville, 2002; Vanhaudenhuyse, Laureys, & Faymonville, 2014) along with increased 
functional and structural connectivity between these regions (Hoeft et al., 2012; Mark P. 
Jensen et al., 2015; Oakley & Halligan, 2013).  In addition, EEG studies have shown a 
consistent dominance in theta wave activity in people who are highly hypnotizable 
(Helen J. Crawford, 1994; H. J. Crawford & Gruzelier, 1992). These individuals typically 
exhibit greater theta activity at rest and during hypnotic induction. Theta activity 
(between 4-8Hz) is associated with drowsiness, memory function and focused attention. 
In addition, hypnotic induction and suggestion has been associated with changes in 
gamma activity (>38Hz) which is thought to be important in memory and recall, and 
coherence of cross-modal sensory processing (e.g. synthesizing parallel sensory 
processing from different brain regions for example sound, sight and smell) (Mark P. 
Jensen et al., 2015). However, the direction of gamma activity is not consistent, with 
some researchers showing a decrease in gamma activity in highly hypnotizable subjects 
(Vilfredo De Pascalis, 2007; V. De Pascalis, Cacace, & Massicolle, 2004; V. De Pascalis, 
Marucci, Penna, & Pessa, 1987). Whilst others show a decrease (Akpinar, Ulett, & Itil, 
1971; Schnyer & Allen, 1995). 
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 Review Questions 1.11
Taken together, these studies have shown that hypnosis results in changes in brain 
activity in several brain regions that are also considered important in pain processing. 
Whilst there are several reviews assessing the brain involvement in hypnotic analgesia of 
experimental pain, there are very few focused on chronic pain. Therefore, the aim of the 
current review is to examine the current research findings on the brain processing 
during hypnotic analgesia in chronic pain. Specifically the aims of the current review are 
assess: 
1. What are the brain mechanisms of hypnotic analgesia in chronic pain? 
2. How generalizable are the findings from the current literature; a discussion of 
study design 
3. What are the clinical and research implications? 
 
 Methods 1.12
 
Systematic search strategy 
Potential studies for review were identified using a systematic approach to 
searching.  
An online search for relevant journal articles was carried out using three electronic 
databases; PsychINFO, Medline and Embase. The following search terms were applied:  
 
Chronic pain or pain or nociception or pain perception 
AND 
Hypnosis or Hypnotherapy or clinical hypnosis or hypnoanalgesia or hypnotic analgesia or hypnotic 
AND 
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Functional magnetic resonance imaging or FMRI or positron emission tomography or PET or arterial 
spin labelling or ASL or electroencephalogram or EEG or magnetoencephalography or MEG or 
functional neuroimaging 
 
Inclusion criteria for search 
• Studies on individuals with chronic pain 
• Using functional brain imaging 
• Clinical hypnotic modulation of chronic pain 
• Examined brain response during hypnotic modulation of actual pain (i.e. not 
imagined pain) 
• Participants were adult humans 
• Written in English 
• Published between 1995 (to coincide with the first use of functional MRI) and 
the present day 
• Published in a peer-reviewed journal 
Following this, records were screened for duplicates across databases. Abstracts 
were then screened for inclusion/exclusion criteria. Finally, full text articles were 
assessed in further detail for eligibility based on inclusion criteria. 
 
  Results  1.13
A schematic overview of the search process can be found in Figure 1.4. A total of 
437 articles were identified across the 3 databases (Embase 259, Medline 99, 
PsychINFO 79). An initial screen excluded 48 animal studies, 44 articles that were not 
published in English, and 23 articles that were published before 1995, resulting in a 
remaining 322 articles. Duplicates were then removed, resulting in 218 articles (Embase 
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192, Medline 16 and PsychINFO 20). Following this, the abstracts and titles of the 
articles identified were screened against inclusion/exclusion criteria. Of these, 180 
articles were excluded. A significant number (76) were excluded as they were not 
functional neuroimaging studies on hypnotic modulation of pain; a large number of 
these were studies on pharmacokinetics and anaesthesia, pharmacological modulation of 
brain activity, studies on the hypnotic effects of opioids and studies on insomnia. A 
further 104 were excluded for the following reasons; 67 were review articles, 27 were 
conference proceedings/abstracts, 5 were book chapters and 5 were editorials. 
The remaining 38 articles were screened further by reading the full publication. 29 
of these were excluded as they did not include hypnotic modulation of chronic pain and 
were focused on functional brain imaging of acute experimental pain or imagined pain 
in normal healthy volunteers. This resulted in 9 studies eligible for inclusion in the 
current review (Abrahamsen et al., 2010; S. W. G. Derbyshire, Whalley, & Oakley, 2009; 
M. P. Jensen, 2013; M. P. Jensen et al., 2016; M. P. Jensen, Sherlin, et al., 2014; 
Nusbaum et al., 2011; Rosen, Willoch, Bartenstein, Berner, & Rosjo, 2001; Wik, Fischer, 
Bragee, Finer, & Fredrikson, 1999; Willoch et al., 2000), summarized in Table 1.1. 	  
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Figure 1.4 PRISMA flowchart showing an overview of systematic search strategy and results 
(Moher, Liberati, Tetzlaff, & Altman, 2009)  
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Table 1.1 Summary of studies included in review. PET=Positron emission tomography; fMRI=functional magnetic resonance imaging; EEG=Electroencephalography; CP=chronic 
pain; PL=phantom limb; NS=not stated; ACC=anterior cingulate cortex; S2=secondary somatosensory cortex; PFC=prefrontal cortex; SMA=supplementary motor area; 
S1=primary somatosensory cortex; BA=Brodmann area 
 
Author Imaging 
technique 
N (mean age) Pain stimulus Pain disorder Chronic 
Pain 
duration 
Brain regions modulated by hypnotic analgesia 
Jensen et al., 
2016 
EEG 20 (12 female, 
mean age 49 
years) 
None – modulation 
of on-going CP 
Multiple sclerosis >6 months Increased: theta activity, left frontal cortex 
Jensen et al., 
2014 
EEG 30 (22 male, 
mean age 49 
years) 
None – modulation 
of on-going CP 
Spinal cord injury >6 months Increased: theta activity, frontal and posterior cortical 
areas and less significant in central areas 
Decreased: gamma activity, left frontal cortex 
Jensen et al., 
2013 
EEG 30 (22 male, 
mean age 49 
years) 
None – modulation 
of on-going CP 
Spinal cord injury >6 months Increased: theta activity, left frontal cortex; Alpha 
activity, diffuse and non-localized (whole cortex) 
Decreased: gamma activity, non-localised, mainly central 
regions of the cortex 
Nusbaum et al., 
2011 
PET 14 (all male, 
mean age 41 
years) 
None – modulation 
of on-going CP 
Chronic lower back pain >3 months Increased activity: Anterior insula, ACC (BA32), medial 
prefrontal cortex, Caudate nucleus accumbens 
Abrahamsen et 
al., 2010 
fMRI 19 (18 male, 
mean age 41 
years) 
Pressure – pin prick Temporomandibular 
disorder (TMD) 
>6 months Decreased activity: Right posterior insula, S2, middle 
temporal cortex 
Derbyshire et 
al., 2009 
fMRI 13 (all female, 
mean age 51 
years) 
None – modulation 
of on-going CP 
Fibromyalgia NS Increased activity: Midbrain, thalamus, ACC (BA24), S1, 
S2, insula, inferior parietal cortex, prefrontal cortex 
Rosen et al., 
2001 
PET 2 (all male, 
mean age 30 
years) 
Imagined painful 
position or 
movement of PL 
Phantom limb (PL) >6 months Increased activity: right insula, right ACC 
Decreased activity: bilateral thalamus, bilateral SMA, 
bilateral S1 
Willoch et al., 
2000 
PET 8 (6 male, 
mean age? 
range 25-68) 
Imagined painful 
position or 
movement of PL 
Phantom limb (PL) NS Increased activity: SMA, S1 
Wik et al., 1999 PET 8 (all female, 
mean age 47 
years) 
None – modulation 
of on-going CP 
Fibromyalgia NS Increased activity: bilateral PFC, bilateral subcallosal 
cingulate gyrus, right thalamus, left S2. Decreased activity: 
bilateral mid ACC (BA24), bilateral posterior CC 
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 Relevant review 
 
There have been several reviews over the past decade on the functional 
neuroanatomy of hypnosis (e.g. (Dillworth, Mendoza, & Jensen, 2012)). The systematic 
search identified the most recent and most relevant review to the present review (Del 
Casale  et  al.,  2015),  published  in  2015.  Del  Casale  et  al.,  reported  on  the  recent 
functional neuroimaging studies on pain perception and hypnosis. In their review, they 
reported  brain  correlates  during  imagined  pain,  experimental  pain  in  patients  and 
healthy volunteers during hypnotic analgesia. 
The proposed review aims to build on that by Del Casale et al., in several ways. 
Firstly, the current review includes findings from studies using EEG which was a 
technique excluded by Del Casale et al. As a result, the present review includes four 
additional studies on chronic pain, compared to the five studies described by Del Casale 
et al. In addition, whilst Del Casale et al. described the findings from the studies 
included in their review, they did not offer a critique on the methodological approaches 
of the studies and therefore the generalizability of the findings summarized in their 
review is unclear. A second additional aim of the present review therefore is to critically 
evaluate the current literature on neuroimaging studies of chronic pain and hypnosis and 
propose areas for development in future research. 
 
 
 
Summary of findings 
 
As can be seen in Table 1, the most commonly reported areas involved in 
hypnoanalgesia are the ACC, insula, thalamus, S2 and frontal cortex. Whilst the EEG 
studies are limited in the localization of activity, it is clear that there is predominance 
towards prefrontal cortex activity implicated in hypnoanalgesia. However, despite an 
apparent similarity between studies, it is also noteworthy that despite common regions 
implicated, there are no studies that report the same ‘network’ of regions. Furthermore, 
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there are differences in direction of activity, with some showing increased activity during 
hypnoanalgesia and others showing decreases in the same regions. All studies, with the 
exception of one (Abrahamsen et al., 2010) show increases in brain activity during 
hypnoanalgesia, with two of those also showing decreased activity.  
 
 Discussion 1.14
Review aim 1; What are the brain mechanisms of hypnotic analgesia in chronic 
pain? 
Hypnoanalgesia involves regions involved in the pain processing: Not surprisingly perhaps, 
the most common regions implicated in the studies reviewed (ACC, insula, thalamus 
and S2 and frontal cortex) overlap with those show to be involved in processing of pain 
in health and chronic pain. Perhaps unexpectedly, these regions are predominately those 
previously implicated in more emotional and cognitive modulation of pain and not 
sensory processing per se. This is surprising as all studies reported a decrease in pain 
during hypnoanalgesia, which one might expect would result in a change in activity in 
sensory areas, most notably the S1. This may suggest that the peripheral/sensory 
component of the pain has not been altered but that emotional and cognitive aspects 
have been modulated through hypnosis treatment. 
Frontal cortex: The majority of the studies (6 out of 9) suggest a role of the frontal 
cortex in hypnoanalgesia. This is in line with previous suggestions that this area is 
pivotal in a descending modulatory (pain inhibiting) pathway (Berman et al., 2008; 
Fields, 2000; Lorenz, Minoshima, & Casey, 2003; Mayer, Naliboff, & Craig, 2006; 
Villemure & Bushnell, 2002). It is also a region that has been shown to be more 
prominent in patients with chronic pain (Apkarian, Bushnell, Treede, & Zubieta, 2005).  
Baseline brain function and hypnotic modulation: The three EEG studies, most notably 
Jensen et al. (2014), provide an insight into how resting brain function might be 
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involved in hypnotic analgesia of pain. In contrast to the PET and fMRI studies 
described, these data are not focused entirely on measuring change in response to 
evoked pain during hypnotic modulation. They describe brain states, in particular 
increased theta activity in the PFC is related to hypnotic analgesia, whereby greater theta 
activity is associated with pain reduction during hypnosis. Jensen et al. (2016) also 
demonstrated how neurofeedback training in theta activity enhances hypnotic analgesia. 
One could argue that theta activity is not specific to hypnotic analgesia and is related to 
hypnosis in general, however the effects described above were not shown in other 
neuromodulatory pain treatments, providing stronger evidence of this effect being 
specific to hypnotic analgesia (Jensen, 2013). 
 
Review aim 2: How generalizable are the findings from the current literature; a 
discussion of study design 
Despite synthesizing the results of the studies reviewed as a whole, it is also 
clear that whilst a consensus can be argued, there is also a significant amount of 
variability in the findings. In part, this is likely to be due to the small number of studies 
reported on the particular topic reviewed, with such a small number there is likely to be 
more variability. 
 
Sources of variability between studies 
Method of stimulation: There was a range of types of pain and methods of evoking 
pain described across the studies reviewed ranging from imagined limb movement (e.g. 
Rosen et al., 2001) to pin prick (Abrahamsen et al., 2010). This offers several sources of 
variability including stimulation of different afferent pain pathways (e.g. a variety of pain 
fibers activated depending on stimulation method) which has been show to involve 
differing brain regions and stimulus duration (e.g. pin prick is a short sharp pain 
(milliseconds/second), compared to constant ongoing background pain (e.g. Wik et al., 
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1999). Evoked pain compared with ongoing background pain also has a number of 
other psychological differences related to anticipation, threat and salience which are also 
known to influence brain activity during pain (Gregory et al., 2003; Naliboff et al., 2008; 
Ploghaus et al., 2001; Ploghaus et al., 2000).  
Sample size: There was also a wide range of sample sizes and types of chronic 
pain groups studied. Sample size ranged from 2 to 30, with the majority (six studies) 
involving fewer than 20 participants. Although the exact number of participants 
required to adequately power a functional neuroimaging study is unclear, it is generally 
accepted that a minimum of 12-16 volunteers are required in order to begin generalizing 
the findings. Certainly, the case series described by Rosen et al (2001) which reported 
data on two individual patients lacks statistical power and therefore the findings are very 
limited in terms of generalization. These data are likely to be considerably affected by 
type I and type II errors, as are the findings of Willoch (2000) and Wik (1999). 
However, the later studies described (from 2009 – 2016) appear to be adequately 
powered to detect significant effects without such error.  
Study populations: There was also a variety of pain conditions studied in the papers 
reviewed (2 fibromyalgia; 2 phantom limb pain; 1 chronic lower back pain; 1 TMD. 2 
spinal cord injury; 1 multiple sclerosis). One could argue that aside from the different 
peripheral input, all pain is essentially processed in the same way at a central level. 
However, there is likely to be significant heterogeneity in both physiological and 
psychological processing of different types of pain which would contribute to variability 
between the studies described. 
Image processing and analysis approach: Across the studies there was a wide range of 
statistical analysis package used to analyse brain imaging data, the use of which can 
result in significantly different findings as the philosophy behind the analysis can be 
extremely different e.g. parametric (e.g. SPM, http://www.fil.ion.ucl.ac.uk/spm/) versus 
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non-parametric (e.g. XBAM, http://brainmap.co.uk/), approaches to brain data 
(Brammer et al., 1997; Penny, Friston, Ashburner, Kiebel, & Nichols, 2011). There is no 
consensus on which package to use, with the approach taken often driven by factors 
such as the Institute in which the study is situated and the availability of analysis 
software and support. Whilst there has been a move towards using two approaches 
(SPM (Penny et al., 2011)and FSL (Jenkinson, Beckmann, Behrens, Woolrich, & Smith, 
2012)) there will still be difficulty in interpreting differences found by research teams 
using differing approaches. Making data available to several research groups through 
collaboration may enable these differences to be assessed which could be a research 
implication of the findings described herein. This is something that is already happening 
in many pain fields. 
In addition to analysis software, there were other differences in analysis 
approach i.e. whole brain versus a priori region of interest (ROI) approach (2 studies 
ROI, 2 ROI and whole brain, 5 whole brain only). Such differences are likely to produce 
significant variability across studies. Using an a-priori approach reduces the number of 
multiple comparisons required (compared to whole brain) and arguably makes it more 
likely to find significant effects in those brain regions examined. However, this approach 
risks missing potentially important changes in other areas of the brain not hypothesized 
to effect change. This means excluding potentially pivotal, novel findings that may 
contribute to existing knowledge on brain mechanisms of hypnoanalgesia. Given the 
limited understanding of mechanisms of hypnoanalgesia it could be argued that a more 
exploratory, whole-brain approach is warranted before ROI approaches are used to 
examine more nuanced, hypothesized effects. It is likely that the two studies exclusively 
using an ROI approach (Rosen, Willoch, Bartenstein, Berner, & Rosjo, 2001; Willoch et 
al., 2000) did so as a result of the low sample size, which would be more affected by 
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correction for multiple comparison across a while brain compared to several a priori 
regions.  
 
Review aim 3; What are the clinical and research implications? 
Despite the variability across studies in terms of methods and techniques, there 
are several clinical and research implications to consider as a result of the findings 
described. 
Assessing connectivity of brain regions: Compared to other area of research using 
functional brain imaging, the current literature on hypnotic analgesia in chronic pain 
seems somewhat dated. The studies found largely report modulation of individual brain 
regions with little attempt to explore how those brain regions might be related or 
connected, other than through interpretation. Brain imaging acquisition and analysis 
techniques now permit the investigation of how brain regions talk to one another by 
using connectivity analysis approaches. This has moved functional imaging away from 
phrenology, and somewhat deductive interpretation and towards a more realistic 
discussion of networks of regions acting in symphony. Such research has identified 
emotional arousal networks, salience networks and homeostatic networks, amongst 
others. Such networks may prove to be important in mediating hypnosis effects on pain, 
not least given EEG data showing widespread synchronous activity as being pivotal in 
hypnotic responding. 
Other brain imaging modalities: In addition to connectivity analysis, other pain 
research has also moved ahead in terms of using other more suitable brain imaging 
techniques to study chronic pain. fMRI and PET are largely reliant on study design that 
use evoked, transient stimuli and are not particularly well suited to measuring brain 
activity to ongoing, chronic pain, which perhaps explains the paucity of chronic pain 
data in relation to hypnosis. The relatively recent introduction of Arterial Spin Labeling 
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(ASL) provides an alternative approach which is more suited to studying less transient 
effects such as hypnotic analgesia and provide an absolute measure of perfusion in the 
brain. Indeed, it has recently been used to brain activity during normal fluctuations in 
pain (Hodkinson et al., 2013; Howard et al., 2012; Owen, Bureau, Thomas, Prato, & St 
Lawrence, 2008; Wasan et al., 2011) 
Brain stem imaging: Given the importance of the brain stem in pain facilitation and 
inhibition, there is a rationale for studying this region in detail when examining pain 
modulation by using an ROI approach and high resolution imaging of this region. 
Given the role of nuclei within this region in autonomic control it is surprising that 
there appear to be no studies that have examined this region in hypnotic modulation of 
pain, not least given the relaxation element of hypnosis which involves autonomic 
arousal/rest which is known to be controlled by brainstem autonomic nuclei. Whilst this 
is a less exploratory, hypothesis driven and perhaps ‘risky’ approach it may provide 
valuable information on mechanisms of hypnotic pain modulation. 
What works for whom?: The findings by Jensen et al. (2014 & 2016) suggest a 
possible role for EEG in treatment of chronic pain. Firstly, they suggest that it may be 
possible to identify individuals more likely to respond to hypnotic analgesia, thereby 
streamlining clinics and avoiding treating ‘non-responders’. Secondly, these results also 
suggest that training people using neurofeedback has a beneficial, additive effect on 
hypnotic analgesia. Taken together, these data if applied to clinical practice could 
conceivably result in more efficient use of hypnosis as a treatment option. Caution is 
required however, as these results are preliminary and require replication, and testing on 
larger samples and across different pain conditions. In addition, there are practical 
considerations of using an EEG in clinics which in itself may be costly and time 
consuming. Perhaps as psychologists, our role could be to phenotype ‘responders’ and 
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develop a questionnaire and validate it against EEG data to provide an alternative, easy 
to administer way of assessing suitability for treatment. 
The apparent role of the frontal cortex in hypnoanalgesia, combined with the role 
of theta activity in this area suggests a possible role for trans-cranial magnetic 
stimulation (TMS). TMS uses a magnetic coil to stimulate brain local cortical brain areas 
without the need for invasive electrode implants. There is already evidence for use of 
TMS in several centrally mediated problems including pain (J.-P. Lefaucheur et al., 2014; 
J. P. Lefaucheur, 2012). This is a speculative clinical implication that would require 
further exploration and research however, recent research has shown an additive effect 
of TMS of the prefrontal cortex on hypnotic suggestibility (Dienes & Hutton, 2013). 
Given the findings of the current review it is possible that there may be a similar role for 
TMS in hypnotic analgesia. 
 
 Summary and conclusions 1.15
Taken together, functional brain imaging studies on hypnotic modulation of pain 
suggest hypnoanalgesia recruits a number of brain regions previously implicated in 
cognitive and emotional modulation of pain.  However, there is a paucity of functional 
neuroimaging studies investigating brain mechanisms involved in hypnotic analgesia in 
chronic pain. Those reported vary significantly in imaging approach, populations studied 
and method of stimulation. Furthermore, the data reported describe independent brain 
regions showing change in the context of an evoked pain. Future research would benefit 
from exploring connectivity between regions and networks involved in pain modulation 
as well as using alternative methods such as ASL to examine absolute changes in 
perfusion in response to hypnotic modulation of pain. EEG data provide a rationale for 
exploring baseline brain activity predicts pain modulation. Such studies may offer 
potential clinical implications such as pre-selection of patients more likely to benefit 
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from a hypnosis approach to pain management. Finally, the long-term impact of 
hypnosis on pain and brain function remains an unexplored area. Research here may 
help clarify whether pain and brain changes following hypnosis are transient or stable 
and long lasting. 
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2 Part 2: Empirical Paper 
Exploring the Processes and Psychological Factors Involved 
in Hypnotic Modulation of Chronic Pelvic Pain 
 Abstract 2.1
Background and Aims: Chronic pelvic pain (CPP) is a debilitating condition often 
associated with significant psychological difficulties such as anxiety and depression. 
There is increasing experimental and clinical evidence for the effectiveness of hypnosis 
in treating a variety of chronic pain problems, although the usefulness of hypnosis for 
treating CPP has not been reported. Given the paucity of psychological interventions 
for CPP and the increasing evidence of effectiveness of hypnosis in other pain 
disorders, the aim of the current research was to assess the use of hypnosis for reducing 
pain and psychological distress and improving function in people suffering with CPP. 
Methods: A multiple single case approach was employed. 5 patients diagnosed with 
chronic pelvic or abdominal pain participated in the study. Participants attended 2 
baseline visits, followed by 5 treatment sessions and one post treatment visit. A mixed 
methods approach to data collection taken, combining self-report measures and semi-
structured interview to assess a number of outcomes measures before and after 
treatment. Visual, graphical analysis, was used to explore the relationship between 
psychological variables and change in the pain experience of participants before and 
after treatment. Post treatment interviews assessing use and experience of hypnosis were 
qualitatively analysed using Thematic Analysis. 
Results: All participants completed the study. Overall, the results suggest that 
participants benefited from hypnosis treatment but that such benefits varied between 
individuals in terms of sensory, psychological and behavioural effects such as pain relief, 
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acceptance of pain and engaging in more activity. Several of these benefits were 
clinically significant and reliable, notably in terms of pain reduction and less 
catastrophizing. 
Conclusions:	the present study suggest that hypnosis is a valuable treatment approach to 
managing chronic pain and can influence the experience of pain on a number of 
domains including sensory, psychological and behavioural such as pain relief, acceptance 
of pain and engaging in more activity. The varied nature of hypnosis effects was 
reflected in the variety of ways in which hypnosis is applied and practiced. The findings 
also propose a number of potential factors involved in mediating the effects of hypnosis 
on pain relief including psychological (acceptance) and psychophysiological (relaxation, 
worry). Larger sample sizes and more complex analysis (such as regression) are required 
to assess these hypotheses further. 
 
 
 	  
51		
 Introduction 2.2
Pain 
The International Association for the Study of Pain defines pain as “an 
unpleasant sensory and emotional experience associated with actual or potential tissue 
damage” (Merskey & Bogduk, 1994). Importantly, this definition avoids linking pain to 
the stimulus that produced it and highlights the emotional (“unpleasant”) and cognitive 
aspects (“potential” tissue damage). This definition reflects the fact that pain can 
originate centrally and is therefore often experienced in the absence of observable 
organic sensory pathology (often referred to as functional pain syndrome or 
unexplained chronic pain) and is commonly associated with psychological factors such 
as mood and attention.  
	
Psychological influences on pain processing 
The impact of psychological variables on the experience of pain has been well 
recognised in the earliest theories of pain (Zarem, 1966). These and others concluded 
that there was significant “top down” modulation of pain perception by the brain, 
particularly via descending pain modulatory pathways from the cortex via the midbrain 
structures such as the periaqueductal grey matter (Melzack & Chapman, 1973). 
Contemporary theories consider pain a multidimensional experience consisting of sensory 
(localisation and intensity of pain, cognitive (aspects such as attention to pain), and affective 
(level of negative affect associated with pain) components rather than the somewhat 
dated dualistic approach which viewed pain as “organic” or “psychological” (Melzack, 
2001, 2005). Despite evidence to the contrary, a dualistic approach still dominates the 
lay medical model of pain and is still prevalent in medical practice.  
Experimental evidence suggests that pain tolerance increases during distraction and 
positive emotional modulation but decreases when attention is focused on pain or 
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during negative emotional modulation (Coen et al., 2008; Phillips et al., 2003; Tang et 
al., 2008; I. Tracey et al., 2002; Villemure, Slotnick, & Bushnell, 2003; Zelman, 
Howland, Nichols, & Cleeland, 1991). Using brain imaging techniques such as 
functional magnetic resonance imaging (fMRI), researchers have shown a neurological 
basis of psychological modulation of pain which typically involves regions such as the 
anterior insula and anterior cingulate cortex ([ACC] emotional modulation) and frontal 
cortex and ACC (cognitive modulation) (Bantick et al., 2002; Coen et al., 2008; 
Dunckley et al., 2007; Kulkarni et al., 2005). Notwithstanding the sensory component of 
pain, these findings highlight the importance of considering psychological factors in the 
assessment and intervention of individuals suffering with chronic pain conditions. 
	
Chronic pain 
Chronic pain occurs when symptoms persist beyond the normal acute period of 
tissue damage and healing time (greater that 3-6 months). It is debilitating physically and 
psychologically, affects approximately 20%-40% of the population and is a global 
phenomenon. It is generally well accepted that in chronic pain disorders psychological 
factors such as emotional and cognitive processing, as well as stress, play an important 
role. This is reflected in the high association of anxiety and depression in individuals 
suffering with chronic pain (estimated at between 20-40% (McWilliams, Cox, & Enns, 
2003)). 
The effectiveness of standard medical treatment for chronic pain is limited 
(Turk, Wilson and Cahana 2001). For example, a recent meta-analysis exploring the 
efficacy of opioids for chronic pain suggested this pharmacological treatment results in 
relatively small improvements in pain intensity relative to placebo (Baron R (Baron, 
Binder, & Wasner, 2010). Furthermore, the reliance on analgesic medications such as 
opioids which can have significant side effects, limited long-term efficacy, abuse 
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(Ballantyne  & Mao 2003; Ballantyne & Sullivan, 2015) or problems with treatment 
adherence has led to an increased interest in the use of psychological therapies for 
managing chronic pain.  
	
Chronic pelvic pain 
  CPP has been defined as ‘chronic or persistent pain perceived in structures 
related to the pelvis’, including bladder and bowel symptoms (Engeler et al., 2013). CPP 
is a prevalent pain condition with a high burden. The multifactorial nature of CPP 
makes it challenging for clinicians and patients. The lack of relationship between pain 
and extent of pathology can exacerbate the challenge of CPP. Despite surgical and 
pharmacological interventions, many individuals remain in pain without a firm diagnosis 
(chronic pain).  
	
Treatment of chronic pelvic pain 
NICE guidelines (Engeler et al., 2013; Fall et al., 2010) suggest CPP in males 
and females is treated according to several algorithms. If underlying tissue pathology is 
identified then treatment is commonly delivered through surgery or pharmacological 
management. These interventions are often unsuccessful, surgery in particular, as often 
the pain is likely to result from central sensitization and is therefore no longer 
originating in the organ or tissue (Arendt-Nielsen & Graven-Nielsen, 2003; Moshiree, 
Zhou, Price, & Verne, 2006; Nijs et al., 2012; Woolf, 2007, 2011; Zambreanu, Wise, 
Brooks, Iannetti, & Tracey, 2005). When CPP occurs in the absence of an identifiable 
disease, and the absence of organ specific pain symptoms, then a multidisciplinary, 
holistic approach is recommended which includes some or all of sexology, psychology, 
physiotherapy and pain medicine.  Despite these recommendations, there is no clear 
evidence base or recommendation regarding the psychological intervention for CPP. 
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Indeed, a recent Cochrane review of non-surgical interventions for the management of 
chronic pelvic pain suggested that urgent research is required on the effectiveness of 
psychological interventions for CPP (Cheong, Smotra, & Williams, 2014)). However, 
the authors did suggest one approach to research and clinical practice is to extrapolate 
findings from general chronic pain management to that of CPP. 
	
Clinical Hypnosis and pain 
One psychological intervention for chronic pain that has received considerable 
attention in the past decade is hypnosis. This is particularly the case where other 
treatments, including psychological based interventions, have failed (M. P. Jensen & 
Patterson, 2014). Clinical Hypnosis is a procedure in which suggestions for imaginative 
experiences are presented after a hypnotic induction that often includes practice of 
relaxation, deep breathing or focused attention. The individual is guided by the 
hypnotherapist to respond to suggestions for changes in subjective experience (e.g. level 
of pain), perception, sensation, emotion, thought or behaviour. The suggestions are 
often idiosyncratic depending on the presentation and goals of the patient (M. P. Jensen, 
Day, & Miro, 2014). 
There is a growing area of research on hypnosis for treating chronic pain in a 
variety of pain conditions including musculoskeletal pain, visceral pain (e.g. irritable 
bowel syndrome) and neuropathic pain (Flik et al., 2011; Gonsalkorale & Whorwell, 
2005; Oneal, Patterson, Soltani, Teeley, & Jensen, 2008; Prior, Colgan, & Whorwell, 
1990). These studies, which have largely focused on outcomes such as pain reduction, 
have provided good evidence for reducing pain and there are now several RCTs 
showing efficacy of hypnosis for reducing pain in a range of chronic pain disorders (M. 
P. Jensen & Patterson, 2014; Tan et al., 2014). In addition, recent evidence has also 
highlighted other beneficial side effects such as reduction in pain unpleasantness, and 
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improved sleep quality, self-efficacy and confidence, mood and socializing (Crasilneck, 
1979; Crawford, 1998; Grundy et al., 2006; M. P. Jensen, 2006; Melzack & Perry, 1975; 
Sachs, Feuerstein, & Vitale, 1977). 
Despite all the evidence above, the mechanisms of hypnosis for reducing pain 
are still relatively poorly understood. Developments have been made through recent 
neuroimaging work that has shown hypnosis results in changes in brain activity in 
several brain regions that overlap with the those considered part of the cerebral 
signature of pain (Faymonville, Boly, & Laureys, 2006; Irene Tracey & Mantyh, 2007; 
Vanhaudenhuyse, Laureys, & Faymonville, 2014), suggesting hypnosis may work 
through a top-down modulation of pain. The brain regions involved appear to depend 
on the nature of the hypnotic suggestions, i.e. whether there is a sensory, emotional or 
attention focus (Mark P. Jensen et al., 2015). Taken together these data suggest an 
alteration in the integration of sensory, cognitive and affective aspects of the pain 
experience following hypnosis. 
Perhaps the strongest rationale for using hypnosis is that it is a neuromodulatory 
approach that targets supraspinal processing of pain rather than the sensory input itself. 
This is in line with contemporary understanding of pain, i.e. that the pain experience is 
the result of what the brain does with the sensory input rather than the sensory input 
itself. This approach is particularly pertinent in those disorders where there is no 
evidence of sensory dysfunction such as that seen in CPP.   
	
 Research problem 2.3
Despite the wealth of evidence showing the efficacy of hypnosis for a range of 
chronic pain problems, there is a paucity of research examining how individuals respond 
to the use of hypnosis in treating CPP.  This is important as although hypnosis for 
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chronic pain appears to show good efficacy for chronic pain in general, there is variation 
in treatment response between different pain conditions (Dillworth, Mendoza, & 
Jensen, 2012; M. P. Jensen et al., 2014; Stoelb, Molton, Jensen, & Patterson, 2009). 
Moreover, there are very few studies exploring the processes involved in the 
effectiveness of hypnosis; for example, hypnosis interventions typically rely on 
individuals engaging in self-hypnosis on a daily basis between treatment sessions but 
little is known about the way in which self-hypnosis is practiced (i.e. frequency, 
duration, time of day). For example, some individuals may use self-hypnosis when their 
pain reaches a certain level whilst others may use it before or after activity. It would be 
interesting to explore the relationship between self-hypnosis use and change in pain 
outcomes during and following hypnosis treatment.  
In addition, particularly lacking is an exploration of how psychological factors 
such as attention, emotion processing, catastrophizing and hypervigilance may be 
involved in mediating the effect of hypnosis. All these factors are known to be 
important in the exacerbation and maintenance of chronic pain (Bergbom, Boersma, 
Overmeer, & Linton, 2011; G. Crombez, D. M. Van Ryckeghem, C. Eccleston, & S. 
Van Damme, 2013; Eccleston & Crombez, 1999; Garland, 2012; Goubert, Crombez, & 
Van Damme, 2004; Lumley et al., 2011; Westman, Boersma, Leppert, & Linton, 2011). 
Despite this, the majority of hypnosis studies thus far have used global, rudimentary 
measures such as the Hospital Anxiety and Depression scale (HADS)(Zigmond & 
Snaith, 1983) and SCL-R 90 Symptom Checklist-Revised (Derogatis & Unger, 2010), 
largely ignoring other functional and psychological outcomes. 
Finally, it is likely, given the proposed mechanisms of hypnosis, that the effect of 
hypnoanalgesia extends beyond purely inhibiting sensory input and that some of the 
psychological factors thought to influence the experience of pain (as mentioned above) 
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are mediating factors in the usefulness of hypnosis. To date, these factors have not been 
assessed.  
 Research aims 2.4
Using mixed quantitative and qualitative outcomes, and adopting an inductive 
approach, the aim of the study is to generate knowledge on how patients with chronic 
pelvic pain use hypnosis and how that is related to a variety of pain and functional 
outcome measures. This knowledge can then be used to formulate hypotheses for 
future studies in larger cohorts with the aim of assessing the effectiveness and/or 
efficacy of hypnosis for CPP in a more systematic and controlled manner e.g. in 
controlled experiments and randomised controlled trials.  
	
Research questions 
1. Does hypnosis affect intensity and unpleasantness of pain in people with CPP? 
2. How do individuals practice self-hypnosis? 
3. What are the psychological mechanisms that might be involved in mediating 
response to hypnosis? 
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 Methods 2.5
Participants 
Five volunteers (3 male; mean age 35 years, range 19-51 years) participated in the study 
after informed, written consent; the study had ethical approval from the South West – 
Cornwall and Plymouth Research Ethics Committee (reference 15/SW/0345).  
Participants were identified and recruited, following informed consent, from 
consecutive referrals for hypnosis from within the Pain Management Centre at the 
National Hospital for Neurology and Neurosurgery (NHNN), University College 
London Hospitals (UCLH) Queen Square, London. All participants had a diagnosis of 
chronic pelvic or abdominal pain. Potential participants with further planned surgery, 
pelvic inflammatory disease, other major neurological, neurodevelopmental or medical 
illness were excluded. A summary of participant characteristics is presented in Table 2.1. 
 
Table 2.1 Summary of patient demographics, clinical history and therapist allocation 
Participant 
number 
Age Gender Duration 
of pain 
Ethnicity Location of 
pain/diagnosis 
Co-morbid 
problems 
Therapist 
P1 27 male 5 years White 
British 
 
Pelvic pain PTSD 1 
P2 35 male 13 years White 
British 
 
Pelvic pain - 1 
P3 61 female 2 years Arabic Abdominal 
Pain 
Chronic 
Lower Back 
Pain 
(following a 
fall 2 years 
ago) 
2 
P4 26 male 18 
months 
Indian Abdominal 
pain 
IBS, chronic 
constipation 
2 
P5 19 female 8 years White 
British 
 
Abdominal 
pain 
JHS, CFS 2 
JHS=joint hypermobility syndrome; IBS=irritable bowel syndrome; PTSD=post-traumatic 
stress disorder. 
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Design 
A prospective case series approach was employed to address the aims of the 
research proposal. Participants completed mixed quantitative and qualitative measures 
to assess outcomes of the study such as change in average and worst pain intensity and 
distress, psychological functioning (e.g. attentional bias, emotional distress) and 
experience of hypnotherapy for chronic pain. Given the heterogeneity in the delivery 
and proposed mechanisms of hypnosis as well as the multidimensional nature of the 
pain experience, the outcomes selected for this study were broad and aimed at covering 
sensory, cognitive and emotional factors that are hypothesised to change during 
intervention. 
Pre-intervention and post intervention outcomes were collected using self-
report measures (see questionnaire pack, below) and qualitative interview. In addition, 
daily measures of pain (e.g. pain intensity and pain unpleasantness) and pain related 
psychological functioning (e.g. catastrophizing, worry about pain and attention to pain, 
pain interference) were recorded using an electronic daily diary. For a schematic 
overview of the protocol see the appendix. 
	
Procedure 
Recruitment and informed consent: Potential participants were identified by screening 
consecutive referrals to the pain team at the NHNN, UCH. Participants were then 
contacted by telephone to briefly assess suitability for hypnosis and interest in 
volunteering for the research, after which they were invited to attend a clinical 
assessment appointment at UCH with one of the qualified hypnotherapists involved in 
the study (see section on clinical hypnosis procedure). Following this, participants were 
sent a participant information sheet and appointment letter for their assessment, thereby 
giving them a minimum of 48 hours to consider the study and their participation before 
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informed consent was obtained. At their assessment appointment (prior to clinical 
assessment) participants were met by me to discuss and answer any questions about the 
research and obtain informed consent to participate in the study. 
Baseline phase: Following informed consent, participants completed a 
questionnaire pack containing several self-report questionnaires (see below) and a Pain-
Stroop task (see below for more details). After this, they were given instructions and a 
demonstration on how to complete an online dairy diary (see below for more detail) 
which they agreed to complete from that day forward until two weeks after the end of 
treatment. Approximately two weeks later, participants attended their first treatment 
session, prior to which the outcome measures described above were repeated 
(questionnaire pack and Stroop task). This pre-treatment phase was aimed at 
establishing a baseline level of functioning and symptoms prior to hypnosis treatment.   
Intervention phase: during treatment, participants attended their clinical hypnosis 
outpatient appointments as normal at UCLH based on the availability of clinician and 
participant. During this time they also completed an online daily diary. 
Post intervention phase: following the end of treatment, participants completed the 
online daily diary for approximately two weeks. At the end of this period, they attended 
a final research appointment where the baseline measures described above 
(questionnaire pack and Pain-Stroop task) were repeated. Participants were then 
interviewed to assess their experience of using hypnosis and any effects of treatment on 
their symptoms or functioning.  
 For a summary of measurements used and the time points at which measures 
were administered see Table 2.2. 
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Self-report questionnaires (Questionnaire Pack) 
Self-report measures were used to assess a range of study outcomes. Participants 
complete all the questionnaires listed below at baseline (twice) and approximately two 
weeks following the end of treatment.  
The choice of questionnaires was pragmatic and aimed at assessing the 
psychosocial, sensory, cognitive and emotional aspects of pain whilst not over-
burdening participants. In addition to being pragmatic, this approach was aimed at 
ensuring the quality of responses to the questions was not affected by questionnaire-
fatigue. 
	
Psychosocial functioning: 
A common outcome measure in chronic pain research is interference of pain in 
the ability to engage in routine, daily physical activities, otherwise known as health 
related quality of life (HRQOL). This was assessed using the Brief Pain Inventory (BPI) 
(Cleeland & Ryan, 1994). The BPI is a recommended measure of HRQL when 
researching pain (Dworkin et al., 2005) and provides a reliable assessment of pain 
severity and the interference of pain with physical functioning. It has been translated 
into many languages and studied in diverse chronic pain conditions in multiple 
countries. Validation studies include The BPI contains 11 items, comprised of a pain 
severity scale (4 items) and pain interference scale (7 items), each item scored from 0 to 
10. It is a relatively simple questionnaire to complete, score and interpret and is 
applicable across a variety of pain aetiologies (Keller et al., 2004). Means for the severity 
and interference scales are calculated with higher scores representing more severe pain 
levels (range 0-10) and more interference (range 0-10). The psychometric properties of 
the BPI have been explored recently with findings suggesting a good psychometric 
profile: internal reliability 0.82-0.95 (assessed by comparing two groups of chronic pain 
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patients), criterion validity α=0.61-0.74 (assessed by comparing with SF-36 bodily pain 
scale). Furthermore, they also noted that BPI was sensitive to changes in disability for 
the sample they studied (Keller et al., 2004).  
	
Psychological distress:  
The Hospital Anxiety and Depression Scale (HADS) was used to assess 
psychological distress. The HADS is comprised of fourteen items designed to assess 
levels of anxiety and depression through two, 7 item subscales HADS-A and HADS-D 
(Zigmond & Snaith, 1983). The questionnaire was validated within health populations, 
showing good psychometric properties with a Cronbach’s α=.89-.93 (Zigmond & 
Snaith, 1983), test-retest reliability r=.72. In addition, comparisons with other 
questionnaires of psychological distress have shown good convergent validity (r.49 to 
.83) (Bjelland, Dahl, Haug, & Neckelmann). Although there are other measures available 
to specifically assess anxiety and depression, the HADS is preferable when measuring 
such constructs in clinical populations with chronic pain as it does not contain somatic 
descriptions of psychological distress that may overlap with symptoms of chronic pain. 
This reduces the chance of artificially inflated scores of anxiety and depression. Despite 
being developed and validated for use in assessing anxiety and depression separately, the 
HADS has been shown to be more valid as a single measure of psychological distress 
(Cosco, Doyle, Ward, & McGee, 2012). Total HADS scores range from 0 to 42 with 
greater scores representing higher levels of psychological distress. 
	
Worry:  
The Pain Catastrophizing Scale (PCS, (Sullivan, Bishop, & Pivik, 1995) is a self-
report measure containing 13 items that assess catastrophizing, overestimation of threat 
and underestimation of coping, and tendency to attend to pain. Studies have shown 
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high internal consistency (Cronbach’s α=0.91, (Sullivan et al., 1995) whilst the test-retest 
reliability is moderate for the scale as a whole (ICC=0.82) (Chatzidimitriou et al., 2006).  
Respondents are required to rate frequency of responses to pain from 0 (not at all) to 4 
(all the time), range of total score 0 to 52 with higher scores representing increased 
levels of pain catastrophizing.  
The Pervasive Thinking Questionnaire (Ehring et al., 2011) was used as an 
additional measure of worry as it has been suggested that this tool assesses a different 
construct to the PCS that may be important in maintaining pain (Flink, Boersma, & 
Linton, 2013). The PTQ contains 15 items designed to measure extent of repetitive 
negative thinking (RNT). Unlike several other questionnaires measuring RNT, the PTQ 
does not focus on a particular disorder-specific content and is therefore useful for 
measuring RNT across a range of presenting problems where RNT is hypothesised to 
be important, including chronic pain. On a 5-point scale, respondents are requested to 
indicate how they typically think about their problems or negative experiences (e.g. pain) 
with each item rated from 0 (never) to 4 (almost always). Higher scores indicate higher 
levels of repetitive thinking (range 0-60). The internal consistency of the PTQ is good 
(Cronbach’s alpha=0.94-0.95), and convergent validity with other similar measures is 
also reasonable (r=0.63) (Ehring et al., 2011). The PTQ has also been recently validated 
within other clinical populations showing similar psychometric properties (Černis et al., 
2016) and highlighting the utility of the PTQ in measuring a transdiagnostic process 
(Ehring et al., 2011). 
	
Electronic daily diary assessment 
Participants completed an 8 question online diary at the end of each day during 
a pre-treatment baseline period and throughout treatment, to assess sensory, emotional 
and cognitive components of their pain experience. Participants were reminded to 
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complete the diary each day at 7 pm by means of a text message with a link to the 
questionnaire, an example of which can be found at the following url 
http://www.surveygizmo.com/s3/2850663/Hypnosis-and-Pain-Research-Example. All 
items were rated using an 11-point numerical rating scales ranging from 0-10. These 
scales and questions are based upon previous pain studies assessing psychological 
mechanisms involved in pain processing (Crombez, Viane, Eccleston, Devulder, & 
Goubert, 2013; Van Ryckeghem et al., 2013). Daily questions assessing pain intensity are 
based on those recommended as a core outcome measure in clinical trials of chronic 
pain treatments (Dworkin et al., 2005; D. C. Turk & Dworkin, 2004; D. C. Turk et al., 
2003). For a list of questions used see Appendix 1.  
	
Pain Stroop 
The Stroop task (Stroop, 1935) provides an objective measure of attentional bias 
and has been adapted for use in measuring attentional bias towards pain (Crombez, 
Hermans, & Adriaensen, 2000; G. Crombez, D. M. Van Ryckeghem, et al., 2013; Pearce 
& Morley, 1989). In the present study, the Stroop was employed as an objective measure 
to assess whether one of the mechanisms of hypnosis might be in reducing attentional 
bias towards pain and increasing ability to disengage from pain. The task typically 
involves presentation of a list of words written in different colours. Participants are 
asked to name the colour the word is written in whilst ignoring the meaning of the 
word. The task becomes more difficult when the written word is salient to the person 
performing the task resulting in longer response latencies (the Stroop effect). Previous 
studies have shown increased latencies when reading pain congruent words in chronic 
pain patients. This effect is thought to be larger when the words are particularly salient 
to type of pain an individual is experiencing and when the word is a sensory pain word 
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(e.g. throbbing, sharp) rather than emotional pain word (e.g. nasty, punishing) (G. 
Crombez, D. M. Van Ryckeghem, et al., 2013). 
In the present study, participants completed the Stroop task twice during the 
baseline period and once following treatment in order to assess any effect of hypnosis 
treatment on attentional biases (latency times). The Stroop task used was based on that 
previously described by Morley et al 1989. Briefly, participants were presented with four 
word lists 1) colour Stroop control; where each word was written in the corresponding g 
coloured ink e.g. blue written in blue ink; 2) colour Stroop, where ink colour and word 
colour were incongruent e.g. blue written in red ink; 3) pain Stroop control; a list of 
neutral words written in coloured ink 4) pain Stroop; a list of pain related words written 
in coloured ink. Lists were present on A4 card in two columns of 25 words (50 words 
per list in total) containing equal numbers of words printed in blue, red, yellow, brown 
and green ink. Words in each control list were matched for length and frequency of use. 
The pain Stroop control and pain Stroop words were the same as those described by 
Pearce and Morley (1989). Word order was pseudo-randomised such that no word or 
colour could appear twice in succession. A practice list was given before testing with 
two columns of Xs written in the five colours described above to ensure participants 
understood the task and could accurately report the colours. A stop watch was used to 
record latency times for the time taken to read each list from the moment the each 
participant began reading the first word.  For examples of the word lists used see 
Appendix 4 and 5.   	  
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Table 2.2 Measurement time points 
Time point Measures administered 
Baseline 1 BPI, HADS, PTQ, PCS, DD, STP 
Baseline 2 BPI, HADS, PTQ, PCS, DD, STP 
Intervention  DD 
End point BPI, HADS, PTQ, PCS, DD, STP, PII 
BPI=Brief Pain Inventory; HADS=Hospital anxiety and depression scale; PTQ=perseverative 
thinking questionnaire; PCS=Pain catastrophizing scale; DD=daily diary; STP=Stroop; 
PII=post intervention interview. 
	
	
Clinical Hypnosis 
Hypnosis treatment was delivered over 5 sessions by two clinicians qualified and 
experienced in using clinical hypnosis for treating chronic abdominal/pelvic pain. For a 
summary of clinician experience and training in hypnosis see Table 2.3. A standardised 
protocol was used by both clinicians, incorporating factors known to be important in 
delivering hypnosis for chronic pain such considering social (e.g. social 
avoidance/isolation), behavioural (e.g. avoidance of activity), cognitive (e.g. acceptance) 
and emotional (e.g. rumination) factors as well as pain sensation. However, specific 
targets for treatment were driven by formulation of each individual client. As such, 
suggestions used during hypnosis were tailored to the needs of the patient as this has 
been shown to be the most effective intervention and is the approach employed in 
previous clinical hypnosis research on chronic pain, (M. P. Jensen & Patterson, 2014; 
Kirsch, Montgomery, & Sapirstein, 1995). Nonetheless, each clinician adhered to a 
standardized protocol as described below and summarized in Table 2.4. 
Overview of hypnosis protocol: Briefly, the first session was aimed at familiarisation 
with hypnotic induction, using relaxation induction and deepening with imagery 
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combined with use of suggestions for comfort and relaxation. During session two, pain 
sensation was targeted through the use of pain imagery (e.g. pain dial) to help transform 
(e.g. dampen down) the pain sensation. Suggestions aimed at changing relationship to 
pain (e.g. pain becoming less bothersome) were also incorporated. Session three was 
aimed at exploring behavioural context in relation to pain such as avoiding social 
situations/activity through appropriate suggestions and imagery, e.g. imaginal exposure. 
During session four, progress was reviewed and problem solving used to explore any 
barriers/problems, integrated into another hypnotic induction. Session five, targeted 
optimisation of current hypnosis strategies as was as using suggestions for maintenance 
or improvement. 
Each session was recorded on a smart phone and participants were encouraged 
to practice self-hypnosis using the recordings at between sessions. 
Table 2.3 Summary of clinician training and experience of using hypnosis for 
management of chronic pain 
Therapist 1 Therapist 2 
Qualifications relevant to hypnosis intervention: 
• BSc (Hons) Psychology 
• DClinPsy (2007) 
• Diploma in Clinical Hypnosis, UCL 
(2006) 
 
Qualifications relevant to hypnosis intervention: 
• Doctorate in general medicine, MD 
(2003) 
• MSc Hypnosis, UCL (2007) 
• Diploma in Hypnosis, UCL (2006) 
 
Experience relevant to hypnosis intervention: 
Psychology Lead for Complex Pain Team 
and Abdominal Pelvic Pain Pathway, 
University College London Hospitals 
(UCLH) NHS Foundation Trust. Over 15 
years of experience treating chronic pain, 
10 years of treating chronic pain with 
clinical hypnosis. 
 
Experience relevant to hypnosis intervention: 
History of using hypnosis for treating 
chronic pain since 2005. Established the 
first NHS hypnosis service to treat a wide 
range of conditions including pain. 
President-elect of the Hypnosis and 
Psychosomatic Medicine Section, Royal 
Society of Medicine. 
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Table 2.4 Hypnosis intervention summarised session by session 
Session number Session content 
Session 1 
• Familiarisation with hypnotic induction  
• Relaxation induction and deepening with imagery 
combined with use of suggestions for comfort and 
relaxation 
Session 2 
• Pain sensation was targeted through the use of pain 
imagery (e.g. pain dial) to help transform (e.g. dampen 
down) the pain sensation.  
• Suggestions aimed at changing relationship to pain (e.g. 
pain becoming less bothersome)  
Session 3 
• Exploration of behavioural context in relation to pain such 
as avoiding social situations/activity. 
• Exposure to avoided situations using appropriate 
suggestions and imagery, e.g. imaginal exposure 
Session 4 
• Review session. Problem solving any difficulties in 
engagement/use of hypnosis  
Session 5 
• Optimisation of current hypnosis strategies 
• Suggestions for maintenance or improvement of hypnosis 
practice 
	
Post treatment Semi-structured interview 
Approximately two weeks (depending on participant availability) after their final 
hypnosis treatment session, participants attended a final appointment with me. During 
this appointment, participants completed a final questionnaire pack and Stroop, after 
which they were interviewed to assess experience of hypnosis such as what they found 
most helpful and how they think hypnosis affected their pain and well-being. The 
interview, developed in consultation with the research supervisor and hypnosis 
clinicians, was designed to gain an idiographic measurement of experience and benefit 
of hypnosis rather than relying purely on quantitative methods. Interviews lasted 
between 25-40 minutes, were recorded on Dictaphone and transcribed by me. The 
interview was semi-structured and based on a list of pre-defined areas of interest aimed 
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at addressing the study outcomes including practice of self-hypnosis and effects of 
hypnosis on pain and quality of life/daily functioning, as well as probing cognitions 
about pain. The list of topics for discussion can be found in the interview schedule 
(Appendix 7). Although the interview was structured, the schedule was used as a guide 
and alternative or follow-up questions were used where appropriate, these are also 
contained in Appendix 7. Many of the additional questions that were used were 
analogous to those used in the standardized client change interview (Elliott, 1999), 
although questions were focused on addressing research questions of the study and 
were therefore not as broad as the interview by Elliot and colleagues.    
	
Statistical Analysis 	
Questionnaire, daily diary and Stroop 
Due to the small sample size, the use of group level inferential statistics was not 
possible as a minimum number of approximately twelve is required in order to have 
enough statistical power to detect an effect and avoid type II error. As a result, analysis 
of baseline-endpoint data was calculated at an individual level using reliable change and 
clinically significant change were possible (Jacobson, Roberts, Berns, & McGlinchey, 
1999; Jacobson & Truax, 1991; Morley & Dowzer, 2014). Reliable change (RC) refers to 
a change in score that is more than the expected error of the measurement tool, whilst 
clinically significant change (CSC) refers to a reliable change that is also clinically 
relevant. Briefly, clinical significance, in the absence of an established cutoff for clinical 
caseness, is estimated using one of 3 criteria; criterion A) when scores are outside the 
range of a clinical population (more than 1.96 standard deviations towards a non-clinical 
reference sample); criterion B) when scores fall within the range of a non-clinical 
population; criterion C) when scores fall closer to the mean of the comparison group 
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than the clinical group, see Figure 2.1. When calculating CSC it is preferable to use 
criterion B or C when data for a non-clinical population is available (Jacobson & Truax, 
1991; S. Morley & Dowzer, 2014). However, as there were no normative population 
statistics available for the BPI, criterion A was used in this instance. For all other 
measures where normative data was available (HADS, PCS, PTQ), criterion B was 
applied.  
 
Figure 2.1. Schematic of Jacobson’s criteria for estimating clinically significant change, taken 
directly from Morley & Dowzer (2014). 
 
Using the criterion described above, reliable and clinically significant change were 
calculated using statistics summarised in Table 2.5 and according to the method 
described by Morley & Dowzer (2014).  
Where RC or CSC was not possible, qualitative analysis was applied by 
graphically analysing data for each individual, according to previous guidelines for 
single-case data (Morley & Adams, 1991).  
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Baseline:  
A composite baseline score was used (calculated by obtaining the mean value of 
baseline measure 1 and baseline measure 2) as a representative baseline score for all self-
report questionnaire data (HADS, PCS, BPI and PTQ) but not daily diary outcomes. 
This score was then used to compare with outcomes obtained at the end of treatment. 
	
Self-report questionnaires: 
For each participant, mean scores were calculated for the BPI pain severity and 
pain interference constructs at baseline and post intervention. These data were plotted 
graphically and analysed for RC and CSC. For HADS, PCS and PTQ, total score was 
calculated for each participant at baseline and post intervention for each measure and 
plotted graphically then analysed for RC and CSC.  
 
Pain Stroop:  
Latency times for each condition at baseline and end of treatment were plotted 
graphically for each participant and analysed visually. 
	
Daily diary: 
Data were summarized by calculating mean weekly scores for each outcome (e.g. 
pain intensity, pain unpleasantness, avoidance) for each participant. These were plotted 
graphically to show change weekly from baseline to post intervention. Error bars were 
calculated and added to each graph to represent variability in scores for each mean 
calculated. In addition, baseline and end of treatment scores were calculated for pain 
intensity and pain distress measures in order to assess if there was a clinically significant 
change in pain ratings (30% change from baseline)(Dworkin et al., 2005). 
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Table 2.5 Reliable change statistics for all measures 
Measure Published clinical 
population 
Clinical 
population mean 
(SD) 
Reliability 
coefficient 
    
BPI (Keller et al., 2004) 
(Tan, Jensen, 
Thornby, & Shanti, 
2004) 
P=6.98 (1.79) 
I=7.56 (2.01) 
α=0.84-0.95 
    
HADS (Morley, Williams, 
& Hussain, 2008) 
20.85 (7.2) α=0.89-0.93 
    
PCS (Osman et al., 1997) 20.9 (12.5) α=0.93 
    
PTQ  (Ehring et al., 2011) 28.1 (13.23) NCS α=0.95 
	 	 	 	
BPI=Brief Pain Inventory (P=Pain subscale, I=Interference subscale); HADS=Hospital anxiety 
and depression scale; PTQ=perseverative thinking questionnaire; PCS=Pain catastrophizing 
scale; NCS=non clinical sample 
	
	
Interview data: 
Thematic analysis (TA) was used to analyse and interpret the data gathered at 
post intervention interview as this provided the most pragmatic approach to answering 
the research question (Pistrang & Barker, 2012). Thematic analysis is a systematic 
method involving several pre-defined stages (see below) of analysis that is suitable for 
identifying and analysing patterns of meaning in qualitative data sets (Joffe, 2011). 
Unlike some alternative qualitative methods, TA allows a combination of a deductive 
(researcher led ideas, hypotheses or topics are used to interpret data) and inductive 
(content of the data drives topics, idea and themes and outcomes) approach to data 
analysis reflecting the fact that it is a suitable approach for research from different 
epistemological positions (Braun & Clarke, 2006, 2012). Although a primarily deductive 
approach was taken in analysis of the interview transcripts, TA was selected as it also 
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enabled opportunity for emergence of themes outside the hypothesis and research 
questions of the project (inductive).  
Transcripts were analysed across three domains which reflected the research 
questions and structure and content of the interview; 1) Practice of self-hypnosis, 2) 
Effects of hypnosis on pain levels, 3) Effects of hypnosis on psychosocial functioning 
(e.g. behavior, cognitions and emotions about pain).  
Thematic analysis procedure: A six stage protocol was used to analysis the data as 
previously described by Braun and Clarke (2006). Each recording was transcribed 
verbatim by the researcher, ensuring any personal information was removed that might 
make participants identifiable. This process is a useful step if carried out by the 
researcher as it adds an extra layer of familiarisation with the data compared to 
outsourcing transcription. Following transcription, all transcripts (data) were read and 
preliminary comments were noted.  The data were then re-read and any text that 
seemed to describe (explicitly or latently) phenomena congruent with the research 
questions were noted. These items were given initial codes, which refers to the most 
basic element of the raw data (Braun & Clarke, 2006). Using these codes, themes were 
then identified by grouping conceptually similar codes, leading to a preliminary thematic 
map of the data for each individual. Following this, the complete data set (all 
participants’ transcripts) were read again and reviewed to ensure themes were 
heterogeneous and codes homogenous. During this stage any necessary recoding or 
changes to themes were made as a result of the review of the entire data set. This 
resulted in an updated thematic map that closely mirrored the data and consistently and 
accurately reflected elements of the research question. Following this, themes were 
defined and labeled. Finally, in order to illustrate the occurrence of themes in individual 
participant responses, extracts of raw data were selected which reflected each theme.  
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Researcher perspective 
It is well described that researchers bring their own perspective to analysis of any 
type of data and that this can influence the data analysis, data collection and 
interpretation and are therefore active agents in the research process (Braun & Clarke, 
2012). This influence is particularly relevant when considering qualitative analysis. As 
such qualitative methodology guidelines recommend that perspectives of the researcher 
are disclosed so that the results can be better evaluated by the audience. I am a white 
male in my mid-thirties from an Irish working class background. I am a clinical 
psychologist trainee at UCL, prior to which I spent several years working as an 
experimental psychologist conducting research in functional brain imaging and pain. 
Through this work I have developed a good knowledge of top-down modulation on 
pain (cognitive and emotional) whilst also gaining a good understanding of the 
physiology of pain. As a result I adopt a biopsychosocial approach to assessment and 
understanding of chronic pain. I have personal experience of long-term mild pain as a 
result of several sporting injuries, but this does not affect my physical activity. I also 
have experience of relatives with pain conditions, secondary to other physical health 
problems and have seen the effect pain can have on physical ability and emotional well-
being. Through these experiences I have noticed the disparity between level of 
pain/injury and level of disability/ function and observed how psychological factors 
mediate this difference in functional outcomes between individuals. In summary, I have 
personal and professional experience with chronic pain which will influence my 
interpretation of the data and perhaps my follow-up interview questions. In order to 
reduce personal bias in the research process, I have used regular research meetings, 
supervision and personal reflection to acknowledge and partition my own beliefs and 
assumptions (Hill et al., 2005). Furthermore, an example transcript was independently 
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coded by another researcher involved in the study ad differences in coding were clarified 
and updated as necessary. 
 
 Results 2.6
All participants completed baseline, intervention and post intervention visits. In 
addition, they attended all their clinical sessions. Due to differences in clinician and 
participant availability there was a range of treatment period from 6-8 weeks.  
	
Daily diary 
Response: all participants responded to the daily diary requests. However there 
was some variability in number of daily responses, with all participants responding a 
minimum of twice per week (range 2-7 responses per week). On days where volunteers 
responded, all questions in the diary were answered. In total, individual responses varied 
from 61% completion to 100% completion (P1=90%, P2=83%, P3=100%, P4=61%, 
P5=79%). Average weekly responses to each question are summarised graphically in 
Figure 2.2 to Figure 2.9. 
Pain intensity and pain unpleasantness: visual graphical analysis revealed that all 
participants showed a decrease in pain intensity and unpleasantness ratings from 
baseline to end of treatment. Visual analysis suggested the changes in PI were mirrored 
by changes in PU except in P1 who showed a greater gradual decrease in PU. When 
baseline and end of treatment scores were analysed for CSC, results demonstrated that 
there was a CS reduction in PI and PU in P4 and P5, whilst P1 showed a CS reduction 
in PU only.  Most of the changes observed show a gradual slow decrease over the 
period of treatment (e.g. P1, P2, P3). However, the graph of PU and PI for P4 show a 
big at week 3 when treatment started whereas the drop in PU and PI seen in P5 seem 
show most change after the final treatment session. 
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Finally, error bars show some variability in within each week for all volunteers. 
This was most notable for P4 and P5, who showed very high variability in scores, 
suggesting pain levels were dramatically changing on a daily basis. Anecdotally this is 
analogous to verbal reports from P4 and P5 who suggested their pains are very episodic 
and changed day to day compared to P1-P3 who reported more steady pain levels. 
Focus on pain and distraction by pain: visual inspection of the FP and DP graphs 
show that responses over time were mirrored for these daily questions, reflecting the 
fact they were measuring similar outcomes. Overall, scores show high between subject 
variability in how much people focused on their pain or were distracted by pain from 
low (P1, P5) to moderate (P2, P3). P1 and P2 showed little notable change from 
baseline to end of treatment with low variability from week to week. P3 and P5 showed 
a gradual decrease in DP and FP scores from beginning to end of treatment. P4 showed 
high variability in scores at during baseline with very high scores before treatment and a 
dramatic drop at the start of treatment which was then mostly stable week by week (low 
for the rest of the study). Both P4 and P5 showed high variability in scores within each 
week, reflected by large error bars.  
Worry about pain: reported worry about pain varied between subjects with some 
reported low (P1, P5), moderate (P2, P3) and high levels (P4). Worry was stable across 
time for P1 and P2 with no change from baseline. P5 showed a reduction from low 
worry to no worry from baseline to end of treatment. P3 and P4 showed changes in 
weekly worry levels that fluctuated around moderately high levels but there was no 
apparent change when scores at the beginning and end of study were assessed. 
Effects of pain on activity: Scores on HA, SD, ad AV questions showed remarkably 
similar weekly plots, reflecting the fact these questions measured similar effects of pain 
on daily activity. P1 reported low scores on all measures, with a small reduction over 
time suggesting pain did not limit daily activity substantially before treatment and 
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therefore there was a floor effect for this participant on this outcome. Nevertheless, it 
does appear that variability decreased over time with more days at the beginning than at 
the end of treatment when pain affected daily activity. P2 showed moderate levels of 
effect of pain on activity, but this effect showed very little variability week by week and 
there was no notable change from beginning to end of treatment. P3, P4 and P5 all 
showed a change in HA, SD and AV scores from baseline to end of treatment. Graphs 
of P3 and P4 suggest a gradual decrease of influence of pain on activity from start to 
end of treatment whilst the change in P4 appears to be a result of a considerable drop in 
scores when treatment commenced. As with previous measures, P4 and P5 showed high 
variability in weekly scores (large error bars) suggesting scores varied substantially day to 
day. 
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Figure 2.2 Mean weekly pain intensity scores. Each graph shows weekly changes in pain 
intensity for an individual participant from baseline (week 1 and 2) to end of treatment. Daily 
responses to the statement Please rate your pain intensity by indicating the number that best describes your 
pain on average in the last 24 hours were recorded using daily dairy and summarised as weekly 
averages.  
PI=pain intensity; P=participant; SD=standard deviation; 0=no pain, 10= extreme pain 
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Figure 2.3 Mean weekly pain unpleasantness scores. Each graph shows weekly changes in pain 
unpleasantness for an individual participant from baseline (week 1 and 2) to end of treatment. 
Daily responses to the statement Please rate you’re the unpleasantness of you pain by indicating the number 
that best describes your pain on average in the last 24 hours were recorded using daily dairy and 
summarised as weekly averages.  
PU=pain unpleasantness; P=participant; SD=standard deviation; 0=no unpleasantness, 10= 
extremely unpleasant 
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Figure 2.4 Mean weekly focus on pain scores. Each graph shows weekly changes in level of 
focus on pain for an individual participant from baseline (week 1 and 2) to end of treatment. 
Daily responses to the statement Today I have been focussing on my pain were recorded using daily 
dairy and summarised as weekly averages.  
FP=focused on pain; P=participant; SD=standard deviation; 0=not at all, 10= completely 
focused 
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Figure 2.5 Mean weekly distracted by pain scores. Each graph shows weekly changes in level of 
distraction by pain for an individual participant from baseline (week 1 and 2) to end of 
treatment. Daily responses to the statement Today I am distracted by my pain were recorded using 
daily dairy and summarised as weekly averages.  
DP=distracted by pain; P=participant; SD=standard deviation; 0 = not at all – 10 = completely 
distracted.  
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Figure 2.6 Mean weekly worry about pain scores. Each graph shows weekly changes in level of 
worry about pain for an individual participant from baseline (week 1 and 2) to end of treatment. 
Daily responses to the statement I am worried about my pain were recorded using daily dairy 
and summarised as weekly averages.  
WP=Worry about pain; P=participant; SD=standard deviation; 0 = not at all – 10 = completely.  
 
 
0	
2	
4	
6	
8	
10	
1	 2	 3	 4	 5	 6	 7	 8	 9	 10	
M
ea
n	
w
ee
kl
y	
W
P	
sc
or
e	
(+
SD
)	
Week	
P1	
0	
2	
4	
6	
8	
10	
1	 2	 3	 4	 5	 6	 7	 8	 9	
M
ea
n	
w
ee
kl
y	
W
P	
sc
or
e	
(+
SD
)	
Week	
P2	
0	
2	
4	
6	
8	
10	
1	 2	 3	 4	 5	 6	 7	 8	
M
ea
n	
w
ee
kl
y	
W
P	
sc
or
e	
(+
SD
)	
Week	
P3	
0	
2	
4	
6	
8	
10	
1	 2	 3	 4	 5	 6	 7	 8	
M
ea
n	
w
ee
kl
y	
W
P	
sc
or
e	
(+
SD
)	
Week	
P4	
0	
2	
4	
6	
8	
10	
1	 2	 3	 4	 5	 6	 7	 8	
M
ea
n	
w
ee
kl
y	
W
P	
sc
or
e	
(+
SD
)	
Week	
P5	
83		
	 	
	 	
 
Figure 2.7 Mean weekly pain hindrance scores. Each graph shows weekly changes in hindrance 
of planned activity due to pain for an individual participant from baseline (week 1 and 2) to end 
of treatment. Daily responses to the statement To what extent did pain hinder your planned activities 
were recorded using daily dairy and summarised as weekly averages.  
HA=Hindered activity; P=participant; SD=standard deviation; 0 = not at all – 10 = completely 
hindered.  
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Figure 2.8 Mean weekly pain avoidance scores. Each graph shows weekly changes in avoidance 
of activity due to pain for an individual participant from baseline (week 1 and 2) to end of 
treatment. Daily responses to the statement To what extent did you avoid daily activities today because of 
pain were recorded using daily dairy and summarised as weekly averages.  
AV=Avoided activity; P=participant; SD=standard deviation; 0 = not at all – 10 = completely.  
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Figure 2.9 Mean weekly pain stopped me from doing things scores. Each graph shows weekly 
changes in effect of pain on stopping activity for an individual participant from baseline (week 1 
and 2) to end of treatment. Daily responses to the statement Today my pain has stopped me from 
doing things were recorded using daily dairy and summarised as weekly averages.  
SD=Stopped me from doing things; P=participant; SD=standard deviation; 0 = not at all – 10 
= completely.  
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Self-report questionnaire data 
All participants completed all questionnaires at baseline and end of treatment. A 
summary of baseline and end of treatment scores for each measure can be found in 
Figure 2.11 (BPI), Figure 2.10 (HADS), Figure 2.12 (PCS) and Figure 2.13 (PTQ). RC 
and CSC for each measure is summarised in Table 2.6 and plotted in Figures 2.13 to 
2.17. 
  HADS: Overall psychological distress ranged from low (P5) to moderately high 
((P2, P3). Scores between baseline and end of treatment reduced for 4 out of the 5 
participants (P1-P4), but none of these changes observed were reliable or clinically 
significant. In contrast to other participants, P5 reported an increase in psychological 
distress scores at the end of treatment: see Figure 2.10 and Table 2.6 for detailed 
information on scores.  
BPI: Overall, pain intensity and unpleasantness levels were moderate to high 
across the group of participants, with the exception of P1 who reported low pain 
intensity at baseline and end of treatment.  
Pain intensity scores (BPI-I) reduced in two participants (P2, P3), showed no 
change in P1 and P4 and increased to more than double in P5. Analysis of CSC and RC 
demonstrated that only one participant (P3) showed a reliable decrease in pain from 
baseline, with no CS reductions in pain. 
In terms of pain interference on daily life (BPI-I), 3 participants (P1, P2, P3) 
reported reduced interference. However, only one (P1) of these changes was CS and 
reliable. P4 showed no notable change whilst P5 reported increased interference from a 
mean of 1 at baseline to 8 at end of treatment. See Figure 2.11 and Table 2.6 for detailed 
information on scores.  
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PCS: Scores across the group varied from low (P1) to moderate (P4) levels of 
pain catastrophizing. Levels of catastrophizing reduced in all participants from baseline 
to end of treatment. These changes were CS and reliable for P2, P3 and P5. Although 
catastrophizing dropped in P4, scores were high and reduced very slightly. P1 reported 
low catastrophizing at baseline and a small drop from this at end of treatment. See 
Figure 2.12 and Table 2.6 for detailed information on scores.  
  
PTQ: Overall, scores on ruminative thinking about pain varied from low (P1) to 
moderate (P4). Graphical analysis revealed that scores reduced from baseline to end of 
treatment for 3 participants (P1, P3, P5) of which one was CS and reliable (P3). P2 and 
P4 reported no notable change in scores from baseline. See Figure 2.13 and Table 2.6 
for detailed information on scores.  
When the profile of PCS and PTQ scores are viewed graphically, it appears that 
scores were very similar for each individual, suggesting a similar construct was being 
measured. 
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Figure 2.10 HADS scores before and after treatment. Higher scores represent higher levels of 
psychological distress. 
HADS=Hospital anxiety and depression score; P=participant; BL=baseline; End=end of 
treatment 	 	
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Figure 2.11 BPI pain and interference scores before and after treatment. Each graph shows pain 
level (a) and interference level (b) for each volunteer at baseline and after intervention. Higher 
scores represent higher levels of pain and interference respectively. 
BPI=Brief pain inventory; P=participant; BL=baseline; End=end of treatment 
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Figure 2.12 PCS scores before and after treatment. Higher scores represent higher levels of pain 
catastrophizing. 
PCS=Pain catastrophizing scale; P=participant; BL=baseline; End=end of treatment. 
 
	
Figure 2.13 PTQ scores before and after treatment. Higher scores represent higher levels of 
ruminative thinking about pain. 
PTQ=Perseverative thinking questionnaire; P=participant; BL=baseline; End=end of 
treatment. 			 	
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Table 2.6 Summary of outcome scores for baseline and end of treatment with reliable 
change and clinically significant change indicated 
Measure P1 P2 P3 P4 P5 
PI, DD      
Baseline 7 6 6 5 3 
Endpoint 6 5 4 3 0 
Change -19% -9% -22% -45% CSC -100% CSC 
PU, DD      
Baseline 7 6 6 6 4 
Endpoint 4 6 4 3 0 
Change -41% CSC -5% -24% -56% CSC -100% CSC 
HADS      
Baseline 12 26 19 27 6 
Endpoint 6 21 13 23 7 
Change -6 -5 -6 -5 +1 
BPI-I      
Baseline 3 7 6 7 1 
Endpoint 1 6 4 7 8 
Change -2RC, CSC -1 -2 0 +7 
BPI-P      
Baseline 6 6 7 5 2 
Endpoint 7 5 5 5 5 
Change +1 -1 -2 RC 0 +3 
PCS      
Baseline 8 22 28 32 13 
Endpoint 4 13 10 31 5 
Change -4 -9RC, CSC -18RC, CSC -1 -8RC, CSC 
PTQ      
Baseline 5 25 22 38 13 
Endpoint 2 25 14 38 11 
Change -3 0 -8 RC, CSC 0 -2 
RC=reliable change; CSC=clinically significant change; PI=pain intensity, PU=pain 
unpleasantness, DD=daily diary; BPI=Brief Pain Inventory (P=Pain subscale, I=Interference 
subscale); HADS=Hospital anxiety and depression scale; PTQ=perseverative thinking 
questionnaire; PCS=Pain catastrophizing scale. 				 	
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Figure 2.14 Plot of PTQ scores pre and post treatment with reliable change margins and clinical 
cut-offs illustrated 	
	
Figure 2.15 Plot of HADS scores pre and post treatment with reliable change margins and 
clinical cut-offs illustrated. 		 	
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Figure 2.16 Plot of PCS scores pre and post treatment with reliable change margins and clinical 
cut-offs illustrated. 	
	
Figure 2.17 Plot of BPI-P scores pre and post treatment with reliable change margins and 
clinical cut-offs illustrated. 			 	
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Figure 2.18 Plot of BPI-I scores pre and post treatment with reliable change margins and clinical 
cut-offs illustrated. 		
	
Stroop	data	
	
Stroop latencies for classic Stroop task and pain Stroop are summarised in 
Figure 2.19 and Figure 2.20.  
Classic Stroop: All participants showed increased latencies to SI lists compared to 
SC at baseline. All participants showed similar responses at end of treatment. 
Pain Stroop: Overall, latencies to PS and PC showed variability within and 
between subjects at baseline and end of treatment. P1 and P4 showed a slightly longer 
response time to PS relative to PC at baseline whilst P2 and P3 showed shorter response 
times and P5 showing little difference.  
At the end of treatment P2 and P3 showed increased latencies during PS relative 
to PC whilst P4 showed a decrease and P1 showed no difference.  
When PS latencies are compared at baseline and end of treatment, two 
participants (P1 & P4) show a decrease in latency whilst all other participants show an 
increase in response times. 	
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Figure 2.19 Latencies for Stroop congruent and Stroop incongruent trials at baseline and end of 
treatment. 
SC=Stroop congruent; SI=Stroop incongruent 
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Figure 2.20 Latencies for Pain control and Pain Stroop trials at baseline and end of treatment. 
PC=Pain control; PS=Pain Stroop 
 	 	
0	
20	
40	
60	
BL	 End	La
te
nc
y	
(s
ec
on
ds
)	
	
Visit	
P1	
PC	
PS	 31	
32	
33	
34	
35	
36	
BL	 End	La
te
nc
y	
(s
ec
on
ds
)	
	
Visit	
P2	
PC	
PS	
45	
50	
55	
60	
BL	 End	La
te
nc
y	
(s
ec
on
ds
)	
	
Visit	
P3	
PC	
PS	 42	
43	
44	
45	
46	
47	
BL	 End	La
te
nc
y	
(s
ec
on
ds
)	
	
Visit	
P4	
PC	
PS	
0	
20	
40	
60	
BL	 End	La
te
nc
y	
(s
ec
on
ds
)	
	
Visit	
P5	
PC	
PS	
97		
Interview data  
Thematic analysis of the interview data was aimed at addressing research 
questions on practical application of hypnosis outside sessions, effects of hypnosis on 
pain sensation, and effects of hypnosis on behavioral and psychological functioning. 
Several themes were identified through analyzing participant’s responses, these are 
described below with examples to highlight data.  
 
Theme 1: Effect of treatment on pain  
There was a consensus between participants in describing how treatment had 
affected the physical nature of their pain symptoms. Several talked about expectations 
of change prior to treatment, with most suggesting they had little or no expectation on 
hypnosis changing their pain level: 
 
P1: I knew it wasn’t one of these things that just stops pain or cuts it down drastically  
 
P2: …although I knew that a mental approach or attitude does help and have some effect but you 
know I wasn’t expecting my pain to disappear or anything like that. 
 
With the exception of P4 who described high expectations: 
 
P4: …I was going in the hope that it’s going to uncover something and from uncovering that it’s going to 
be a big breakthrough in terms of how the pain is affecting me and I was hoping that maybe I would 
fully recover 
 
When discussing change, most participants described little of no change in their pain 
sensation since the beginning of treatment: 
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P1: No, no change in the pain but I am able to tolerate it a lot more than what I was…the only hard 
part I found is the pain dial, turning the dial down. I could only turn it down so far and then it feels 
like it is getting stuck  
 
P2: I’d say no (impact of treatment on pain) because I think simply it is a physical thing that is 
happening (to me). 
 
P4: the pain was bad and when the pain gets bad it’s really bad and using the recordings doesn’t do too 
much…I realise that it does relax me. But when the pain kicks in it is not helpful at all…its helped 
me in many ways that I probably won't even understand but it hasn’t done anything for the pain directly 
for me  
 
P5: No I don’t have any change in my level of pain more in the way I look at it if that kind of makes 
sense  
 
Many individuals suggested that rather than changing pain sensation, the treatment had 
changed the way the think about their pain: 
 
P1: In a way yeah. It’s not taken the pain down but it has helped me work with it and understand it a 
lot more. 
 
P3: I just do it (the hypnosis) because I feel it keeps me away from the pain because I‘ve got the strength 
not to think of my pain in front of me. 
 
P4: … it has changed my mentality, it’s made my mood much better so that in itself is a big thing. 
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P5: It doesn’t change the time length of the pain it just changes the way that I think about it 
 
Theme 2: Varied application of self-hypnosis 
Several participants noted how they use the hypnosis to manage pain either 
before activity or when the pain is very bad. Others described how they used hypnosis 
routinely, each night before bed. Several participants also stated that they were using the 
hypnosis to help with other problems such as worry, low mood and helping them to 
sleep, not just for their pain management directly. 
 
P1: No (not routinely) I use it as and when I need it. So in response to pain or if I’m sort of planning 
on walking into town today I’ll get into that mind set, that zone and just start walking in that zone 
and it helps me go that little bit further so I’m sort of using it for prior, planning…If I’m struggling 
walking I’ll try and get the pain dial down so that I can just go that bit further  
 
P5: Erm, maybe once or twice a week. I don’t use it every time when I am in pain but sometimes if it is 
really bad then I will use it to try and see if it will help.  
 
As stated, several participants described using self-hypnosis for a variety of applications: 
 
P1: Yeah I use it for everything yeah, not just for pain. Daily, anytime during the day. Basically if I 
can’t sleep I’ll use it while sleeping  
 
P1: Well I use it as relaxation to get through stressful periods. I used it recently to help me with a recent 
bereavement. It helped me feel more upbeat and to get me through a tough time. It helped me a lot. 
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P3: It helps me to sleep. Let me explain, when you put the news on it can be good, bad, horrible you 
know it stressed you. But this, when you listen to it nothing…it releases your stress of the day because 
there is nothing sad or bad or happy or anything so it’s totally pure it is and you just sleep nicely because 
you don’t have to share or feel you know. Even when you listen to music sometimes it could be sad music 
so it affects your feeling, you’re emotional but this makes you forget the whole world, be yourself relax 
and sleep. 
 
P4: I’d get myself relaxed in bed and then I’d put the recording on a while before I go to sleep but just to 
sort of relax me and calm me down and everything and yeah it worked. Sometimes in the morning before 
I got up but not as often erm and sometimes on the bus. 
 
In relation to this, participants gave several examples of using a variety of self-hypnosis 
tapes depending on the problem facing them at any given time. 
 
P5: Erm one of them if I have like a really bad day then I use the one that focus more on the main 
sensation of pain if I am having a down day I will use the one that takes you to your calm place if it's a 
medium day but I feel like I need it then I use the one that focuses on background pain and things like 
that.  
 
P1: I vary them just depending on…well I like a bit of variety so I’ll…it’s very much spontaneous 
what I will use. I mean I think if I’m going for a longer activity I’ll use the last session because it was 
more about the pain dial, trying to get control the pain a little bit. So there are certain ones I’ll use for 
certain activities but other than that it’s just very varied. 
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Theme 3: Relationship to pain 
Perhaps the most common and broad theme was related to how participants 
relate to their pain. Indeed, several elements of this this theme overlap with other 
themes described. Several participants gave the impression that whilst the pain had not 
changed, their relationship with their pain had changed in several ways. Many 
participants described fighting less with their pain: 
 
P1: And just thought we can stop arguing and work together sometimes. I know it’s always going to 
have a say and say no you can’t do that but at least I can try to build that relationship up so that it is 
not such a hindrance and more of a working relationship sort of thing… I am able to tolerate it a lot 
more than what I was. I am able to just work with it rather than fight against it all the time…I am 
able to tolerate it a lot more than what I was. I am able to just work with it rather than fight against it 
all the time 
 
P3: Accept it and don’t fight it. I was fighting myself asking why this, and very angry you know and 
angry with doctors thinking why can’t they sort out that problem for me but now I’m finding a way to 
control it and accept that it happens and there is nothing you can do 
 
P5: Yeah (I was fighting with the pain), I think before treatment I would be thinking I really can’t do 
anything why is it like this. Whereas now I am like okay it’s going to be like that I’ll just go and do 
something else. 
 
There were also several examples of participants showing greater acceptance of their 
pain: 
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P1: Yeah, I see my pain as more of a hindrance now than a big, massive problem. It’s just something 
I’ve got to learn to adapt to. That’s how I see it now, adapt and get used to it and I have done…I 
think I’ve always know that I would need to accept the pain. It’s going to be there for life, it’s not going 
to go away 
 
P2: Yeah I think so, it’s sort of…I suppose there is an acceptance there in that it will flare up so why 
worry about it flaring up, you know yeah. 
 
P3: Yes I gave up (fighting and searching for a cause), I gave up I just think ok they can’t put their 
finger on it so just live with it…yeah, just accept that to get…to accept things, accept your circumstances 
that is the main thing really. So now I have come to terms with my condition but not with anger  
 
P5: Sort of knowing that it might not go away but that there are still things that I can do to help it or 
while I am in pain there are still things that I can do. Yeah that and sort of working on myself deciding 
that there isn’t anything I can do when I am in pain but when I am not in pain I can go and do all the 
things I normally do. So just look forward to the good parts rather than focusing on the bad. 
 
Theme 4: Relaxation  
A further theme that was found suggested that in addition to relating to pain 
differently, participants found that they were more relaxed than prior to treatment. This 
was reflected in several areas. For example, a more relaxed style of thinking: 
 
P1: Well I use it as relaxation to get through stressful periods. I used it recently to help me with a recent 
bereavement. It helped me feel more upbeat and to get me through a tough time. It helped me a lot. 
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P2: I know it will automatically flare up because of any sort of slight anxiety or whatever, it will just 
make it worse but I think I have slightly more confidence now that it’s not the end of the world if that 
happens … Its really difficult but I suppose it does give you a bit more strength to sort of tell yourself 
that you are not going to die or anything and it’s going to be okay. 
 
P3: Before yes I thought about it (the pain) all the time. Now I don’t I try not to, I keep myself busy 
with something. 
 
P4: Erm I’ve realized that if you relax more it’s going to help pain regardless of how it’s affecting 
you… I suppose the relaxation element is the main thing (that has helped).  I guess it’s kind of obvious 
that when you are stressed and thinking and all of that all the time any pain feels worse so your nerves 
flare up or something and you feel the pain a lot more intensely and when you are relaxed you feel it 
less…So I’d use it to just sort of relax me because often when I am relaxed I stop thinking so much 
about all the negatives and all that. 
 
Participants also described a physical feeling of relaxation and feeling less anger: 
 
P3: First of all it takes that anger out of you because it’s true that I was so angry, it takes the anger 
out of your system. So it is very helpful, it gives you hand up you know…. I mean the tension in side of 
you it comes out when you talk about it  
 
Theme 5: Doing More 
The majority of participants described being much more active since starting 
treatment. Several described that they were being active despite being in pain, which is 
something they were not doing prior to treatment: 
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P1: But I’m just I’m more in that mind set of just keep going at it now. Definitely don’t let anything get 
in the way. I’m not letting the pain dictate what I can and can’t do. I’m working with the pain and 
dictating to it that look we can do this, it’s not a big drama. 
 
P3: It does, like today I really felt pain but I didn’t stop I just kept going, I prepared food this 
morning, went to the GP, chemists and I am sitting here now uncomfortable but I am not letting it stop 
me 
 
P4: I mean I’m not, it’s not that I recover from an episode and I’m straight in there doing loads of 
things and I’m continuing with my life but I’m able to do more. I don’t feel as if the pain is going to 
come back on. 
 
In addition, others described being more flexible in terms of choosing activity and 
valuing alternative activity 
 
P5: it doesn’t mean that I can’t do things. I can still enjoy things I used to or some of the things I used 
to even though I am in pain like reading a book or watching a video or something or talking to friends. 
It doesn’t mean I can’t do them it just means that physically I can’t get out to do something like go to 
the park with friends but I can still talk to them 
 
With some people suggesting that the treatment had given them more confidence to do 
more than they were doing before: 
 
P2: The biggest thing for me is dealing with, well not dealing with but just interacting with people. I 
think maybe more so when I was doing it, it gave me a little more confidence I think when I was having 
hypnosis sessions every week 
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 Discussion 2.7
The aim of the study was to assess how people use self-hypnosis, and the effect 
of hypnosis on pain reporting psychosocial function. Within this, the aim was to use 
changes reported in psychosocial functioning, as assessed through quantitative and 
qualitative methods, to build hypotheses on potential mediators of hypnosis. The aim of 
the discussion is to synthesize and consider the findings in relation to these aims. 
 
Summary of results 
Overall, the results suggest that participants benefited from hypnosis treatment 
but that such benefits varied between individuals in terms of sensory, psychological and 
behavioural effects such as pain relief, acceptance of pain and engaging in more activity.  
Summary of Quantitative outcomes: Self-report and daily diary measures suggest a variable 
experience of hypnosis amongst participants. Overall, there was a general (non-
significant) effect on all the outcome measures (psychological and sensory) whereby 
scores reduced at the end of treatment compared to baseline. This was seen with the 
exception of P5 who reported greater scores in most domains at the end of treatment. 
This is likely a result of an episode of severe pain that P5 reported (incidentally) during 
the final end of treatment appointment. This is supported by scores on daily diary, 
which was completed before the end of treatment interview session and shows a general 
decrease in scores for this participant.  
Summary of Qualitative outcomes: The results of the qualitative analysis suggest that 
individuals use hypnosis in a variety of ways, not limited to direct management of pain. 
Indeed, the qualitative results point towards a utility of hypnosis outside management of 
sensory symptoms of pain and more towards psychosocial e.g. acceptance and engaging 
more with valued activities and management of pain related symptoms such as worry, 
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physiological arousal and problems with sleep. These factors may be important in 
mediating clinical reduction in pain, as described by the quantitative data.  
 
Effects of hypnosis on pain 
Interestingly, there was a disparity between daily dairy and BPI-I scores which 
both assess sense The BPI-P data suggests no significantly reduced in pain levels in any 
participants whereas the daily diary data suggests 3 participants reported clinically 
significant change in pain (unpleasantness and intensity). This perhaps highlights the 
importance of collecting more than one post-intervention measure as this could be 
influenced by how the participant is feeling on the data of the measurement rather than 
a more general picture of functioning since treatment. In addition, it supports the 
notion that it is important to measure both intensity and unpleasantness (D. C. Turk et 
al., 2003). This disparity may also be a result of the different parameters used to assess 
CSC between the two measures. However, the fact that P5 reported completed 
reduction in pain on daily diary measures and more than double an increase on the BPI-
P suggests otherwise.  
Compared to quantitative data, it was clear at interview that all participants felt there 
was no change in pain sensation. One could suggest that this perhaps reflects the 
treatment approach which, whilst including some focus on reducing pain symptoms, 
predominately addressed issues beyond pain reduction. However, this finding is 
consistent with literature suggesting patients who notice change and are satisfied with 
treatment do not always report changes in pain levels and that hypnosis has significant 
benefits beyond pain relief (M. P. Jensen & Patterson, 2014; Dennis C. Turk, Okifuji, 
Sinclair, & Starz, 1998). More generally the aim of treatment targets beyond pain relief is 
reflected in guidelines for outcome measure in pain research and practice, which 
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emphasizes the need for measures of HRQoL (D. C. Turk & Dworkin, 2004; D. C. 
Turk et al., 2003).  
 
Psychosocial function 
Activity: Scores on the BPI-I showed no significant effect of pain on 
psychosocial function, except in one participant. The data gathered at interview however 
was more effective at elucidating change in daily functioning. All participants described 
being more active at the end of treatment and that they were able to act on goals and 
desires inspire of still experience pain. For some this meant changing the type of activity 
whilst for others it was more about pacing and using hypnosis to calm the pain or 
worries about engaging in activity.  
Relationship to pain: Perhaps the most rich and common theme identified by 
analysis of the interview data was the way in which participants’ described a change in 
the way they relate to their pain.  Interestingly, the changes that several participants 
described in relation to this theme were analogous to goals of acceptance and 
commitment therapy (ACT), a third wave CBT approach to pain management. This 
approach moves away from targeting symptoms of pain and towards behavioural and 
psychological responses to the symptoms. ACT emphasis the need for psychological 
flexibility when living with a long term condition, encourages patients to acknowledge 
their pain but rather than focus on it and allow it to dominate it aims to encourage 
individuals to accept the pain is there but act in ways according to their values (Hayes, 
Strosahl, & Wilson, 1999; McCracken & Vowles, 2014). Such psychological flexibility is 
something that often appears to reduce when people are living with chronic pain. For 
example, they may ruminate on the significant targets they cannot achieve whilst de-
valuing other activities they previously engaged in. Examples of how ACT aims to 
address such patterns of thinking and behaving may be by, being flexible in choice of 
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activity depending on how the pain is on a given day, and learning to find alternative 
ways to socialize (e.g. via the telephone). These are behaviours and ways of thinking 
about pain that individuals reported as changing during treatment the current study.  
Whilst such changes are made at a cognitive level, they have the added benefit of 
increasing activity and daily function, which is known to have a beneficial effect on pain. 
Including elements of ACT has been proposed as important in updating approach to 
traditional CBT methods when treating chronic pain (McCracken & Vowles, 2014) and 
has also be hypothesised to be a possible target when applying clinical hypnosis to 
chronic pain (M. P. Jensen & Patterson, 2014). The results of the current study suggest 
that this is a realistic and clinically effective approach. 
  Pain catastrophizing: Interestingly, there were reliable and clinically significant 
reductions in pain catastrophizing in two of the three participants who reported CSC in 
pain intensity, which may suggest thinking style could be a possible mediator in terms of 
change in pain responses and other variables such as change in activity. Alternatively, 
this change in catastrophizing could simply reflect a change in emotional meaning of 
pain. Finally, the reduction in catastrophizing may have been effected by the benefits of 
relaxation which was a theme identified at interview. 
 
Disparity of qualitative and quantitative outcomes 
It is interesting to note that many of the scores reported using self-report 
measure at beginning and end of treatment were in conflict with changes described by 
participants at interview. An example of this is that all participants reflected on the fact 
they are doing much more at the end of treatment in spite of their pain but only one 
person showed CS and reliable change on the measure used for assessing this (BPI-I). 
This is likely to reflect the fact that the BPI-I measures more than just functional 
interference (also emotional too) but perhaps also highlights the limitation of using 
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quantitative outcomes that can be relatively blunt tools, depending on how well a 
measure fits with a research outcome. In contrast, pain scores on daily diary and BPI-P 
suggested that in total 3 individuals reduced in pain unpleasantness and pain intensity 
over the course of treatment which conflicts with the fact that at interview all 
participants suggested the intervention did not change their pain level. Such 
discrepancies could be due to gathering retrospective data at interview compared with 
the ‘real-time’ daily measurements of pain. 
 
Factors mediating change 
Despite areas of discrepancy in the data, when the quantitative and qualitative 
data are combined then it appears that there was a reduction in pain and an increase in 
daily activity, overall. There was also a reduction in several psychological outcomes such 
as worry, anxiety and relationship to pain. It is challenging to determine what effect 
comes first i.e. does the pain reduction allow for a more active, enjoyable life or does 
engaging in activity lead to psychological benefits and learning that encourages more 
movement which has a beneficial effect on pain levels and/or pain reporting. 
For many patients, the reality when they reach the point of psychological 
intervention is that several attempts (physical therapy, surgical and or/pharmacological) 
have been made to influence the physical element of pain, with limited success. It is 
understandable therefore that treatments that are more psychologically based, such as 
hypnosis described in the present study, do not focus explicitly on pain reduction as a 
primary target and instead emphasize the factors that may be exacerbating pain or 
indeed the beliefs around pain and activity, for instance. Through these approaches, a 
side effect may be pain reduction but it is the way an individual adapts and lives within a 
context of chronic pain that is often a primary goal of the patient and the clinician. 
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One theory is that the physiological component of pain remains constant but 
the reporting of those symptoms and impact of the problem on the person is reduced as 
patients find ways of coping and getting on with life. In the present study one of the 
factors mediating this could be acceptance.  
Biopsychosocial formulation: One query that commonly arises in relation to hypnosis 
is in relation to how it works. It is of course likely that the mediating effects of hypnosis 
on pain outcomes is multi-factorial as discussed above. Given this, it may be helpful 
when considering the factors mediating change in the present study by considering a 
biopsychosocial formulation, summarized in Figure 2.21. Using the data from the 
current study there are several interacting features that may explain the changes 
described.  The effect of relaxation is both biological and psychological in that it is 
known to reduce physiological arousal and has an analogous effect on psychological arousal. 
These effects of relaxation in the present study are therefore likely to reduce level of 
rumination, catastrophizing, worry which are factors known to facilitate pain. In 
addition, reduced physiological arousal is also known to reduce pain facilitation via 
engagement of parasympathetic ANS activity and reduction of sympathetic activity 
(Farmer et al., 2014). Furthermore, physiological arousal has also been linked with a pain 
facilitating effect via inflammatory pathways and upregulation of genes involved in pain 
transmission, for example (Peace et al., 2012). Relaxation is likely to reduce such effects. 
In addition to relaxation, psychological changes such as increased acceptance is likely to 
result in participants being more able to disengage from pain, thereby lowering 
hypervigilance and rumination which are both known to facilitate pain. Finally, 
increased activity is known to increase positive affect and in the case of the present 
study is useful in testing beliefs about the effect of activity increasing pain (which is 
often described by people suffering with chronic pain), improving muscle function and 
tone and enable more opportunities for distraction from pain, all of which are known to 
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inhibit pain. Given all the above, it is likely that the effect of hypnosis is mediated 
through various interacting biopsychosocial mechanisms (Mark P. Jensen et al., 2015; M. 
P. Jensen & Patterson, 2014). 
	
	
	
Figure 2.21: Shows the hypothesized mediating effects of hypnosis by using a biopsychosocial 
formulation of pain 
	
Stroop 
The Stroop task was employed as an objective measure to assess whether one of 
the mechanisms of hypnosis might be in reducing attentional bias towards pain and 
increasing ability to disengage from pain. The fact participants responded with increased 
latencies to the SI task compared to SC at baseline and end of treatment indicates that 
volunteers understood the task and that methodology (i.e. contextual extraneous 
variable such as setting, word size, colour) was suitable for eliciting a Stroop effect. The 
results of the pain Stroop were extremely variable which makes interpretation 
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challenging. Nonetheless, there was no evidence to suggest that participants in the 
present study ‘Strooped’ thereby indicating there was no change in attentional bias in 
the sample studied. 
This finding is possibly due to the fact that the majority of participants did not 
appear to excessively focus on pain, as is evidenced by daily scores of DP and FP. In 
fact, the only participant (P4) who showed high FP/DP scores at baseline which 
reduced at the end of treatment was the only individual to show a change in attentional 
bias i.e. removal of pain Stroop effect after treatment. 
However, it is more likely the results described in the present study are due to 
the reliability of the Stroop. Whilst effects have been shown, there is substantial 
variability in observing the pain Stroop effect with small effect sizes (G. Crombez, I. 
Viane, et al., 2013). Indeed, several authors have suggested that attentional bias to pain 
related information in chronic pain in general may not be as robust as often assumed 
(Schoth, Nunes, & Liossi, 2012; Van Ryckeghem & Crombez, 2014). Given the small 
effect sizes seen when measuring attentional bias, it is likely that the small sample size 
and fact that data was analysed on an individual level rather than group level is also a 
critical factor in ability to detect attention bias in the present study.  
Furthermore, it has been suggested that the pain Stroop effect is best accounted 
for by mood state of chronic pain patients rather than pain per se (Pincus, Fraser, & 
Pearce, 1998). This may well account for the fact that the only participant (P4) who 
showed Stroop effect also reported the highest levels of psychological distress whilst the 
majority of the rest of the sample reported low to moderate levels of distress. 
The use of the Stroop may have been improved by using individualised pain 
descriptions in the word list as that has been shown to increase the effect (G. Crombez, 
D. M. L. Van Ryckeghem, C. Eccleston, & S. Van Damme, 2013).  
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Clinical implications 
Evaluating outcomes at a patient and service level: The findings from the present study 
demonstrates the importance of gathering quantitative and qualitative outcomes in 
evaluating change and feeding back change to patients but also in service evaluation. As 
studying questionnaire outcomes in present study would suggest small clinical gains, 
however, patient descriptions suggested significant changes to their quality of life. If 
such outcomes are overlooked, the benefits may be of treatment difficult to justify and 
service funding may be affected or a patient may not receive the most effective 
treatment.  
For similar reasons, the value in gathering data on a more frequent basis is 
clearly important, particularly given the variability seen in daily pain scores in the present 
study. This could be possible via a measure of daily pain using an electronic online diary 
as an outcome. Such data may capture clinically significant changes that are not gathered 
at start and end of treatment alone.  
 
Use of hypnosis in chronic pain management: The hypnosis treatment approach applied 
in the present study is very similar to pain management programs or one to one 
psychological treatment for chronic pain but implemented over fewer sessions. It is 
possible that the effect of changing rigid cognitive styles (such as 
catastrophizing/acceptance) in relatively few sessions may be achieved in the 
unconscious delivery of information which is unique to hypnosis. Indeed, although not 
reported in the results, it was clear during interviews that participants were not 
consciously aware of the suggestions employed by the therapist and mentioned only the 
relaxation element of the tapes used for self-hypnosis. This suggests that therapeutic 
objectives for change were delivered without the normal ‘cognitive filter’ applied. The 
obvious clinical value of this is reduced number of treatment sessions, which is 
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beneficial to services and service users alike. There may also be a clinical benefit in the 
unconscious delivery of suggestions for behavioral and cognitive change, particularly for 
those patients who are extremely resistant to change or to the application of clinical 
psychology in pain management.  
 
Limitations 
The aim of the study was to recruit a sample of 12 patients. However, as a result 
of a various number of factors including R&D approval, clinician availability for 
hypnosis and difficulty recruiting suitable patients the final sample was considerably 
affected. Whilst this is a significant limitation for studies relying on group analysis, the 
nature of a case series is that it is not dependent on large sample sizes and what is lost in 
numbers is balanced by richness and depth of the data. Nonetheless, with a larger 
sample it may have been possible to (cautiously) employ group level inferential statistics 
to explore if some of the observed changes may have reached statistical significance at a 
group level. It should be noted however that even with 12 participants the conclusions 
and generalizability of such analysis would be limited.  
In relation to the above point, due to changes in availability of clinician resource 
to deliver hypnosis treatment it was necessary to use to clinicians to administer 
treatment. Whilst this may have introduced some variability into the study, it was 
necessary in order to complete the study on schedule. The potential effects were limited 
by clinicians agreeing a protocol for intervention and also by each participant receiving 
treatment by only one clinician. Furthermore, it is likely that there is within clinician 
variability in treatment due to the formulation driven nature of the intervention. This 
may reduce the expected added variability of a second clinician, as described above.  
In order to address several of the research questions, I used an interview 
schedule that was developed and approved by myself, supervisor and hypnosis 
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therapists. The interview questions were designed to specifically address the research 
aims and hypotheses. As such, the breadth of questions was relatively narrow and 
focused on probing specific hypotheses. Whilst this was helpful in gaining specific 
responses to our research questions, there is an increased risk of introducing bias in 
responses and questions could be considered leading. An alternative approach would 
have been to use a broader interview schedule such at the Client Change Interview 
Schedule (Elliott, 1999). This would help reduce bias and perhaps allow a more ‘natural’ 
narrative of change, thereby providing information outside the hypothesised 
mechanisms. As with all approaches to gathering such data, there is no gold standard or 
‘correct’ method. However, there are clearly techniques and approaches that can be 
employed to reduce potential bias. It is worth noting that whilst conducting interviews I 
monitored my questions and was mindful of introducing bias. In doing so, I found 
myself using broader questions similar to those found in the more standardised, broader 
Client Change Interview. Future studies may benefit from using a broader tool such as 
the Client Change Interview with more specific, hypothesis driven queries appended. 
 
Some mention of the design of the case series employed in the current study is 
worthy of discussion. The present study employed an AB design with multiple baseline 
measures (daily diary and self-report questionnaires) and one post-intervention 
outcome. Such designs have been criticised for lacking the potential to experimentally 
reverse treatment and observe effects on dependent variables, which can serve to 
strengthen the association between treatment and effect, thereby increasing internal 
validity (Morley, 2015).  
This AB approach was chosen for several pragmatic reasons such as time 
available to complete the study in the context of a clinical doctoral training programme 
and patient/therapist availability. In order to utilize more eloquent approaches (such as 
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multiple baseline, randomised treatment onset, on-off interventions, and repeated 
measures or replication) it would have required more therapist/patient availability and 
flexibility, which was identified as a threat to the completion of the study during 
planning and choosing the study design. In addition, some of the alternative case series 
design options are perhaps not suitable for investigating hypnosis treatment which is 
something that requires several sessions and practice over time, compared with other 
approaches such as pharmaceutical treatments which may be more amenable to 
‘switching’ on and off. Furthermore, other approaches such as varying treatment dose 
may not be suitable options for similar reasons associated with the nature of hypnosis 
treatment. 
 Despite being limited in choice of design for pragmatic reasons, the design 
employed was optimised from the simplest AB designs by including multiple baseline 
measures and daily measures during the intervention which allowed for exploration of 
how outcomes were changing throughout intervention rather than capturing discrete 
before/after treatment data. Finally, despite the limitations of AB designs, they do 
perhaps contain an ecologically valid assessment of treatment in the real world, which is 
often follows the same format of an AB design (i.e. a single treatment intervention 
programme).  
 
Summary and conclusions 
Despite limitations, the results of the present study suggest that hypnosis is a 
valuable treatment approach to managing chronic pain and can influence the experience 
of pain on a number of domains including sensory, psychological and behavioural such 
as pain relief, acceptance of pain and engaging in more activity. The varied nature of 
hypnosis effects was reflected in the variety of ways in which hypnosis is applied and 
practiced. The findings also propose a number of potential factors involved in 
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mediating the effects of hypnosis on pain relief including psychological (acceptance) and 
psychophysiological (relaxation, worry). Larger sample sizes and more complex analysis 
(such as regression) are required to assess these hypotheses further. 
The findings also highlight the importance of how outcomes are measured and 
how data is gathered influence the quality of the data obtained. Here we described 
differences in approach to asking questions (self-report questionnaire, NRS and 
interview) and varying temporal aspects (real time, high resolution (DD); retrospective 
(interview)) and low resolution retrospective (self-report measures at BL/End of 
treatment). Using a variety of approaches enriched the data but was also important in 
enabling identification of change that would otherwise have been missed. This 
highlights the need for a variety of outcome measures when assessing change in 
research and clinical practice. 	 	
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3 Part 3: Critical Appraisal 
Previous experience and research orientation 
Prior to clinical training, I spent several years working as an experimental 
psychologist in the field of neuroscience and pain. I worked at several research 
institutions where I conducted many research studies, including clinical trials, typically 
aimed at manipulating single independent variables within a controlled environment. My 
research background is very much one where quantitative methodology and analysis 
dominated and a where there was a focus on ‘objective’ outcome measures such as 
change in brain activity or reduction in inflammatory markers in response to an 
intervention.   
This previous experience influenced my research approach and choice of topic 
of research for my research thesis. Firstly, I wanted to continue in an area I had 
experience and published in as this is something I plan to continue after training. 
Secondly, I wanted to improve my research options in terms of methodology and 
analysis away from the predominately quantitative methods and analysis I had 
previously employed and which is most commonly employed in pain research. In 
addition, I viewed the research project as an opportunity to learn and train under one of 
the leading researchers in the field of chronic pain and psychology, which is after all the 
purpose of training. Finally, I was curious about hypnosis as I have heard narratives 
about how it can work well for treating common visceral pain problems such as IBS 
(Whorwell, 2005, 2008) but was aware of a distinct lack on knowledge on how hypnosis 
works (e.g. psychological mechanisms) and how people use it.  
Given my background, at the planning stage of the current research project, I 
initially struggled with the lack of control and sources of variability such a project is 
likely to encounter. As such, my early study designs included fixed clinical visits with 
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one clinician, with set intervals between visits, a fixed baseline period, and a completely 
standardised hypnosis protocol that would be applied to all participants. In addition to I 
aimed to control contextual factors such as always using the same clinic room and 
having appointments at the same time, amongst others. This was because I was already 
considering how to analyse and interpret any data that would be collected and felt it 
would be to challenging to make sense of data with so much ‘background noise’.  To 
some extent I still believe the study would have been improved with all the above 
measures in place. However, I became more aware of the fact that a single case series 
design would enable a more realistic picture of a clinical intervention and outcome that 
would therefore be more relative to future clinical work and perhaps provide a better 
measure of clinical effectiveness.  Indeed, it could be argued that such research with all 
its extraneous variables is more similar to clinical practice and therefore what it lacks in 
assessing efficacy it more than makes up for it in measuring effectiveness and therefore 
is more clinically relevant research. 
Furthermore, at the outset of the analysis I was very much aware of an apparent 
subjectivity in visual graphical analysis and in conducting thematic analysis. However, 
the more I understood the approach in particular the TA method, the more I valued the 
data it provides. This was highlighted by the visual analysis of graphs which highlighted 
the variability in pain scores over time which otherwise would not have been apparent 
in studies examining mean changes at beginning and end of treatment. Furthermore, the 
idiosyncratic nature of the data gathered at interview very much suits the idiosyncratic 
method of clinical intervention which, if formulation driven, is individualised. I also 
valued the data the interview could access that a group of pre-selected self-report 
measures could not assess. These are values I plan to bring to my future research and 
clinical practice (when considering service outcome). 
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Recruitment and working as a research team 
As an experienced researcher, I was aware at the outset of the study that 
conducting clinical research is significantly more challenging and time consuming than 
healthy volunteer research for several reasons, most notably; recruitment (particularly in 
terms of identifying a homogenous patient group) and reliance on experienced clinicians 
for providing the intervention. These challenges were exacerbated by the limited time 
and flexibility I had for attending research visits due to placement commitments. 
Overall, I found this area (recruitment and reliance on other clinicians) perhaps the 
most challenging component of the research process. 
The clinicians involved in the study were excellent and did everything they could 
to make the project work. It was due to factors outside their control that problems 
arose. These problems, although personal to my research, are likely to affect anyone 
conducting clinical research alongside NHS commitments. Through no fault of her 
own, my external supervisor’s NHS role was in a state of constant uncertainty whilst we 
were awaiting ethical approval and did indeed change when the study had approval and 
was set to commence. This change of role resulted in less time to recruit and complete 
intervention and also the amount of time dedicated to project per week was reduced. In 
order to overcome this problem, I enrolled the help of a second clinician and agreed a 
necessary change in the study accepting that the sample size would be less than expected 
but that by combining qualitative and quantitative data collection, the dataset would be 
richer and thicker than initially planned.  I also conceded that the follow-up part of the 
study would need to be omitted. In addition, I combined the first baseline visit with 
clinical assessment which was less than ideal but necessary in order to complete the 
study on schedule. 
This set of circumstances and management of the research highlights the 
importance of flexibility when conducting research in general. Although it is important 
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to aim for the best possible study design, the reality of clinical research is that 
compromises are often made in order to commence and complete the work. This 
flexibility is something that a case series design permits but is not so straightforward if 
conducting other more tightly controlled experiments, such as a RCT for example. Of 
course, were it not for the need to complete the project within a strict timeframe it may 
have been possible to delay the study and limit compromise. However, in my 
experience, research with patients is very rarely without such compromise and the 
limiting factors are often out of the control of the researcher e.g. patient recruitment. 
Such issues are not uncommon and it raises debate about the feasibility of clinical 
trainees conducting clinical research from conception to conclusion. It is possible for 
instance to join an existing clinical study or conduct healthy volunteer research. 
However, despite all the problems I encountered, I still consider being involved from 
conception/study design, navigating the NHS ethical approval process and becoming 
familiar with the realities of clinical research a valuable experience for clinical 
psychologists in training who wish to conduct patient research in the future. 
Difficulties in dissemination 
Perhaps one of the challenges of single case methods is disseminating 
information in a way that is accessible and meaningful to the wider scientific 
community, clinicians and indeed funding bodies (clinical and research). Whilst the data 
can be very rich, as I have found it is sometimes challenging to formulate a cohesive, 
coherent narrative that can be summarised, communicated and therefore easily digested 
by interested parties. This is particularly important in terms of the utility of findings to 
clinical application such that results need to be summarised in a simple enough form to 
prove useful in translating to the clinic. In contrast, larger studies using predominately 
quantitative based methods can reduce clinical practice and outcomes down to a single 
unit or measure, pinpointing particular components of an intervention and weighting 
		128	
them on their importance to change (e.g. through multiple regression). Whilst this 
minimizes individual experience, it provides something tangible to clinicians and 
researchers alike.  
Perhaps, in terms of the present study some of the difficulties may be due to the 
inherent variability that exists in small samples. It may be more realistic to use the 
current findings to formulate hypothesis for larger studies with outcomes tailored to the 
factors that participants cited as key in effecting change so that these ‘mechanisms’ can 
be tested empirically.  
Successes and failures 
I found the use of daily diary very enlightening in that it highlighted the 
extremely high variability in pain experience and the need for ‘real time’ outcomes 
measures when assessing pain. This was the first time I employed such technology for 
research outcomes and it worked extremely well and was very accessible and not 
invasive for patients (i.e. no time consuming).  
In contrast, the Stroop task did not work so well. This element of the research 
was included as a more innovative and potentially risky outcome which is why it was 
conceptualized as a pilot arm to the research and not one of the main aims of the 
project. Nonetheless, it highlights the importance of only including outcomes which it is 
possible to make sense of. It is possible this may have been less problematic had the 
originally anticipated a sample size been recruited, which may have given more weight 
to using quantitative statistics and reduced variability, thereby enabling a clearer picture 
to emerge. 
Influence of dual role of clinician and researcher 
One area that occurred to me as potentially important in the present study that 
might be applied to my research in the future is maintaining balance between clinical 
and research skills. I was aware at several points during the post-treatment interview 
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that I wandered into my clinical role, which was apparent by the type of questions I 
asked or the fact I often reflected back or summarised information in a clinical way e.g. 
“it sounds like you are more accepting of the pain now”. It is now an automatic process 
when engaged in a patient-clinician relationship to continually formulate, reflect, 
hypothesis and summarize.  As I was aware this was happening, I was quickly able to 
move back on track in the interviews. However, this highlights the fact that maintaining 
neutrality when asking questions from a research capacity is key to avoiding potential 
researcher bias influencing participant responses. For example, my summary suggesting 
greater acceptance may have led to acquiescence and therefore compromised the quality 
of the data.  
It is equally important to maintain a good rapport with a patient in order to 
gather as much data as possible at interview. It is perhaps a socially learned behaviour 
that when interviewing individuals familiar with healthcare interactions, the interviewee 
will draw the clinician into their clinical role and that the clinician will naturally gravitate 
towards a clinical role when called upon. It is therefore a two-way process as a patient 
will, most likely, respond differently to someone who is a clinical psychologist compared 
with someone who is a laboratory researcher.  In summary, it appears that when 
conducting clinical research as a clinician, it is important to be mindful of the trade-off 
between using clinical skills to establish good rapport and facilitate drawing out 
information from patients. Whilst at other times using a more neutral focused approach 
may reduce experimenter bias and keep the interview on track towards gathering 
research relevant outcomes.  
Multifactorial nature of pain 
One of the constant challenges when conducting my research (and the literature 
review) was holding in mind all the factors that contribute to chronic pain. The 
complexity of pain is enormous and it was at times overwhelming to reduce that 
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complexity down to a few common factors, psychological mechanisms or behaviours. 
This was apparent in design (i.e. choosing appropriate outcome measures) analysis and 
interpretation. I was always aware that whilst it was not practically possible to measure 
all potential mediating factors, I was missing potentially important outcomes such as 
ANS response which may have been crucial given the number or participants who cited 
relaxation as an important beneficial factor of hypnosis treatment. In addition, at times I 
largely omitted (not deliberately) the physical component of pain, focusing more on the 
emotional and cognitive aspects. This perhaps is natural given the objectives of the 
research but also comes from a personal perspective on chronic pain given my role as 
psychologist and past research interests. What this amounts to is the reality that I was 
only studying a part of the picture/puzzle of hypnotic analgesia for pain. It is perhaps 
unrealistic to think that it is possible to isolate particular causes or moderators of pain 
given the bio psychosocial nature of the condition.  
Research design process 
Patient involvement: Given the limited amount of time available to clinical 
psychologist trainees to conduct research, the time available during the design of the 
research is relatively restricted. In future work it would be ideal to have more space to 
discuss and review protocols amongst the research team but also to extend that 
discussion to other stakeholders, most notably the patient group being studied. It is now 
a pre-requisite for many research projects to have consulted patient representatives prior 
to seeking funding or ethical approval. Given the time constraints this opportunity was 
not taken up. In retrospect this may have been a valuable process as whilst conducting 
the research several participants provided helpful constructive feedback on what could 
have been included/omitted from the research protocol. Perhaps the reluctance (in 
addition to the time constraint) to consult service user groups was that often, in the 
past, I have found expectations of patients to be very high, unrealistic or outside the 
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scope of the research project being planned. Piloting research: With this in mind, I think 
that perhaps the most useful approach would be to fully pilot a study such as the one 
conducted incorporating opportunity for formal feedback and constructive criticism 
from the patients participating in the study. This enables relevant, realistic patient input 
and also provides the research team with an opportunity to notice any potential flaws or 
pitfalls and make any necessary changes to the protocol before studying larger groups. 
Although this may be a time consuming process in the short term, this is something I 
will consider when conducting research in the future as it may save time in the long 
term. 
Conclusion 
Overall, my research experience during clinical training has broadened my 
research horizons and I have learnt a great deal, despite previous extensive research 
experience. I have learnt that it is about using the right tools for the research question at 
hand, so if a technique such as TA is suitable then I will certainly use it again in the 
future. Moreover, my positive experience of the research is a reflection of the excellent 
research and statistical training clinical psychologists receive and the opportunities 
available for clinical research whilst on training. It is not surprising that I have noticed 
how psychologists are valued by other clinical professions (e.g. medicine, nursing) for 
their research knowledge and expertise e.g. on study design and statistics. Yet I have 
also noticed a disparity in the knowledge and training psychologists receive, and the 
confidence and/or desire to carry out research. Furthermore, despite clinical training 
emphasizing the role of the scientist-practitioner psychologist there is a lack of 
dedicated time within clinical roles given to research, which is perhaps the biggest 
barrier to clinical psychologists continuing to build on research skills developed during 
training. With ever-increased waiting lists, this is no doubt a result of the demands of 
clinical practice within the NHS.  My current research however, has given me the 
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confidence that useful research can be conducted on a case-by-case basis, using 
appropriate outcomes measures alongside normal clinical practice and in keeping with 
models of practice based evidence. 
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Appendix 1 - Electronic Daily Diary Questions			Pain	intensity	and	unpleasantness:		 1. Please	rate	your	pain	intensity	by	indicating	the	number	that	best	
describes	your	pain	on	average	in	the	last	24	hours	(0=no	pain,	10=	extreme	pain)		2. Please	rate	the	unpleasantness	of	your	pain	by	indicating	the	
number	that	best	describes	your	pain	on	average	in	the	last	24	
hours	(0=not	at	all	unpleasant,	10=pain	as	unpleasant	as	you	can	imagine)		Avoidance:		 3. To	what	extent	did	you	avoid	daily	activities	today	because	of	pain?	(0	=	‘‘not	at	all’’	–	10	=	‘‘completely	avoid	’’).		Attention:		 4. Today	 I	 have	 been	 focussing	 on	 my	 pain	 (0	 =	 ‘‘not	 at	 all’’	 –	 10	 =	‘‘completely	focused’’).		 5. Today	I	am	distracted	by	my	pain	(0	=	‘‘not	at	all’’	–	10	=	‘‘completely	distracted).			 		Disability:		 6. ‘To	what	extent	did	pain	hinder	your	planned	activities?	(0	=	‘‘not	at	all’’	–	10	=	‘completely	hindered).		 7. Today	my	pain	has	stopped	me	from	doing	things	(0	=	‘‘not	at	all’’	–	10	=	‘‘completely’’).			Worry:		 8. I	am	worried	about	my	pain	(0	=	‘‘not	at	all’’	–	10	=	‘‘completely”).			
Example	scale:		0	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10		 	 	 	 	 	 	 	 	 	 		
Not	at	all	 Completely	
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Appendix 2 –Perseverative thinking Questionnaire 
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Appendix 3 –BPI-P (pain scale) 
	
	 	
BPI-	Pain	Scale	
	
1.   Please rate your pain by circling the one number that best describes your pain at its 
worst in the past 24 hours 
 
 0 1 2 3 4 5 6 7 8 9 10  
No pain Pain as bad as  
you can imagine 
 
 
2. Please rate your pain by circling the one number that best describes your pain at its 
least in the past 24 hours 
 
 0 1 2 3 4 5 6 7 8 9 10  
No pain Pain as bad as 
you can imagine 
 
 
3. Please rate your pain by circling the one number that best describes your pain on 
average 
 
 0 1 2 3 4 5 6 7 8 9 10  
No pain Pain as bad as  
you can imagine 
 
 
4. Please rate your pain by circling the one number that tells how much pain you have 
right now 
 
 0 1 2 3 4 5 6 7 8 9 10  
No pain Pain as bad as  
you can imagine 
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Appendix 4 – BPI-I (interference scale) 
	
	 	
BPI	–	Interference	scale				
5. Circle the one number that describes how, during the past 24 hours, pain has 
interfered with your 
 
A.  General activity 
 0 1 2 3 4 5 6 7 8 9 10  
               Does not  
               interfere 
                                             Completely  
                                           interferes 
 
 
B.  Mood 
 0 1 2 3 4 5 6 7 8 9 10  
Does not  
interfere 
Completely  
interferes 
 
 
C.  Walking ability 
 0 1 2 3 4 5 6 7 8 9 10  
Does not  
interfere 
Completely  
interferes 
 
 
D.  Normal work (includes both work outside the home and housework) 
 0 1 2 3 4 5 6 7 8 9 10  
Does not  
interfere 
Completely 
 interferes 
 
 
E.  Relations with other people 
 0 1 2 3 4 5 6 7 8 9 10  
Does not  
interfere 
Completely 
 interferes 
 
 
F.  Sleep 
 0 1 2 3 4 5 6 7 8 9 10  
Does not  
interfere 
Completely 
 interferes 
 
 
G.  Enjoyment of life 
 0 1 2 3 4 5 6 7 8 9 10  
Does not  
interfere 
Completely 
interferes 
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Appendix 5 – Pain Stroop Control Example 
	
	
	
	
	 	
139		
Appendix 6 -Pain-Stroop Example 
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Appendix 7 Post Treatment interview Schedule 	
• What were your initial expectations of hypnosis, prior to treatment? 
o Was your experience similar/different to expectation? 
o What were your thoughts about how it might affect your pain? 
 
• How have you been using the self-hypnosis techniques? 
o Where e.g. at home, work, bedroom, outside, whilst shopping etc? 
o When e.g. routinely at certain time of day, when pain or emotion is 
particularly bad, before/after activity? 
o Duration, frequency (daily, weekly, minutes) 
o Has your use changed over the course of treatment e.g. slow start but 
now routine? 
 
• What impact has hypnosis had? 
o Was it useful/not useful? 
o Are there any specific aspects that have been helpful i.e. suggestion v 
relaxation? 
 
• Do you understand your pain differently now? 
 
• Has your thinking about pain changed in any way? 
o Worry, daily bother from pain, acceptance 
 
• Has using hypnosis changed anything in your daily life? 
 
• Do you plan to continue using self-hypnosis? 
 
Common al ternat ive/fo l low-up quest ions 
• If you feel there have been changes, what do you attribute those changes to 
(including anything else that was happening in your life outside hypnosis therapy 
that may have influenced change)?  
• What ideas do you have about how hypnosis works? 
• Is there anything you would change about hypnosis therapy (add or take away)? 
• Is there anything you found unhelpful about your treatment experience? 
• Has anyone you know noticed/commented on anything different about you 
since you started therapy? 
• Would I notice you doing anything differently now compared with before 
treatment 
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Appendix 8 – Research Ethical Committee Approval letter
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Appendix 9 – Participant Information Sheet
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Appendix 10 – consent form 	
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Appendix 11: Schematic Overview of Experimental Protocol 
	
